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Background: Brain tumor (BRAT) is a Drosophila member of the TRIM-NHL protein family. This family is conserved
among metazoans and its members function as post-transcriptional regulators. BRAT was thought to be recruited
to mRNAs indirectly through interaction with the RNA-binding protein Pumilio (PUM). However, it has recently been
demonstrated that BRAT directly binds to RNA. The precise sequence recognized by BRAT, the extent of
BRAT-mediated regulation, and the exact roles of PUM and BRAT in post-transcriptional regulation are unknown.
Results: Genome-wide identification of transcripts associated with BRAT or with PUM in Drosophila embryos shows
that they bind largely non-overlapping sets of mRNAs. BRAT binds mRNAs that encode proteins associated with a
variety of functions, many of which are distinct from those implemented by PUM-associated transcripts. Computational
analysis of in vitro and in vivo data identified a novel RNA motif recognized by BRAT that confers BRAT-mediated
regulation in tissue culture cells. The regulatory status of BRAT-associated mRNAs suggests a prominent role for
BRAT in post-transcriptional regulation, including a previously unidentified role in transcript degradation. Transcriptomic
analysis of embryos lacking functional BRAT reveals an important role in mediating the decay of hundreds of maternal
mRNAs during the maternal-to-zygotic transition.
Conclusions: Our results represent the first genome-wide analysis of the mRNAs associated with a TRIM-NHL protein
and the first identification of an RNA motif bound by this protein family. BRAT is a prominent post-transcriptional
regulator in the early embryo through mechanisms that are largely independent of PUM.Background
Post-transcriptional regulation of gene expression plays an
essential role in numerous biological processes in a variety
of cell types. One context in which post-transcriptional
regulatory mechanisms are particularly important is the
earliest stages of embryogenesis, during which the zygotic
genome is transcriptionally quiescent, and development is
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creativecommons.org/publicdomain/zero/1.0/the mother’s genome and loaded into the oocyte during
oogenesis [1]. In the early embryo, gene expression is con-
trolled post-transcriptionally via regulation of mRNA
translation, stability, and localization by trans-acting fac-
tors such as RNA-binding proteins (RBPs) and micro-
RNAs (miRNAs), which bind to cis-acting sequences
present in their target transcripts. The passing of develop-
mental control from maternal to zygotic gene products,
referred to as the maternal-to-zygotic transition (MZT),
involves large-scale degradation of the maternally derived
mRNAs, which is mediated by two different types of deg-
radation machineries, one type dependent exclusively on
maternally derived factors (referred to here as ‘maternal’icle distributed under the terms of the Creative Commons Attribution License
which permits unrestricted use, distribution, and reproduction in any medium,
. The Creative Commons Public Domain Dedication waiver (http://
) applies to the data made available in this article, unless otherwise stated.
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on zygotically expressed factors (referred to here as ‘zygotic’
or ‘late’ machineries) [1,2].
Drosophila Brain Tumor (BRAT) plays an essential
role during the DrosophilaMZT by repressing the transla-
tion of maternal hunchback (hb) mRNA in the posterior
of the embryo [3]. BRAT is a member of the TRIM-NHL
family of proteins, which are conserved among metazoans.
Indeed, BRAT-mediated repression of hb has served as a
model for understanding the mechanisms by which
TRIM-NHL proteins function as post-transcriptional reg-
ulators. BRAT regulates hb expression in cooperation with
Nanos (NOS) and the PUF-family RBP, Pumilio (PUM)
[3]. In embryos from pum, brat, or nos mutant mothers,
HB protein is ectopically expressed in the posterior of the
embryo, leading to a loss of abdominal cell fates and em-
bryonic lethality [3-8]. A role for TRIM-NHL proteins as
post-transcriptional regulators and cell fate determinants
is not limited to Drosophila (reviewed in [9,10]). For ex-
ample, the mammalian TRIM-NHL protein, TRIM71,
functions in the reprogramming of differentiated cells into
induced pluripotent stem cells through its ability to bind
to and inhibit translation of EGR1 mRNA [11] and a re-
cent study has shown that TRIM71 can both repress
translation and induce mRNA degradation [12].
In Drosophila, regulation of hb translation by the BRAT-
PUM-NOS complex is mediated by two Nanos Response
Elements (NREs) in the hb mRNA’s 3′UTR. Each NRE
contains two sequence motifs, which are known as Box
A and Box B. The Box B motif matches the PUM
consensus-binding site, UGUANAUA where N = A/C/
G/U, and is directly bound by PUM’s C-terminal PUF-
homology domain, which is a conserved RNA-binding
domain (RBD). An earlier model to explain hb regula-
tion proposed that PUM and NOS make direct contact
with the NREs and each other, while BRAT is recruited
via its interaction with PUM and NOS proteins
[3,5,13-16]. Recent work, however, has demonstrated
that BRAT directly associates with sequences in and
around hb’s Box A motifs in a PUM-independent man-
ner via its C-terminal NHL domain [17]. That mamma-
lian TRIM56 and TRIM71 are cross-linked to poly(A)
RNA after exposure of cells to UV-irradiation [18,19] is
consistent with the ability of BRAT to bind directly to
RNA.
In addition to their role in repressing hb mRNA in
early Drosophila embryos, PUM, BRAT, and NOS have
been shown to cooperate in regulating other mRNAs in
different cell types. For example, a PUM-NOS-BRAT
complex controls motor neuron excitability through
binding and regulation of paralytic (para) mRNA [20],
and these three proteins cooperate in regulation of
dendrite morphogenesis in the larval peripheral ner-
vous system [21].PUM and BRAT also function together, and likely in-
dependent of NOS, to repress mad and dMyc mRNAs
and thereby promote germ-line stem cell differentiation
during oogenesis [22]. In addition, PUM and NOS can
regulate mRNAs independent of BRAT. For example,
PUM and NOS act together, and without BRAT, to regu-
late cyclin B mRNA in primordial germ cells [3,23,24].
Experiments in tissue culture cells have demonstrated
that PUM can mediate repression of reporter mRNAs
independently of both BRAT and NOS [25]. Likewise,
BRAT appears to exert functions independent of PUM.
For example, in addition to defects in abdominal develop-
ment in embryos from brat mutant mothers, mutations in
brat cause over-proliferation of neuroblasts in the larval
brain, which leads to the production of tumorous over-
growth [26-30] that can metastasize upon transplantation
into the abdomens of adult flies [31]. Flies mutant for
pum, however, do not share this neuroblast overgrowth
phenotype, suggesting that it represents a function for
BRAT independent of PUM. Moreover, BRAT can repress
reporter transcripts in a PUM-independent manner in cell
line-based assays [17], supporting the notion that BRAT
can function independent of PUM.
Despite the aforementioned examples, however, the
extent to which PUM and BRAT cooperate versus act
independently remains unclear, and whether BRAT has
any functions independent of PUM in regulation of en-
dogenous targets in vivo is uncertain. Moreover, the
spectrum of RNA sequences recognized by BRAT has
not been defined, and the range of mechanisms that
BRAT employs to regulate its targets has not been
explored.
To address these questions, and to identify potential
novel biological functions for PUM and BRAT in early
embryos, we have carried out genome-wide identifica-
tion of the mRNAs associated with PUM and with
BRAT. Our results demonstrate that each RBP is associ-
ated with hundreds of mRNAs in early embryos, less
than one-third of which are co-bound by both RBPs. In
addition, through both computational analysis of BRAT-
associated mRNAs as well as in vitro assays, we have
identified a consensus RNA motif bound by BRAT, the
functional significance of which was confirmed using lu-
ciferase reporter assays in Drosophila tissue culture cells.
Gene ontology (GO) term analysis of the functions of
PUM- and BRAT-associated mRNAs suggests a number
of novel biological roles for PUM and BRAT in early
embryos. Analysis of the translational status and stability
of PUM and BRAT mRNA targets reveals that: (1) tar-
gets of both RBPs are translationally repressed; (2) PUM
targets are degraded primarily during the late phase of
the MZT; and (3) BRAT-associated mRNAs are de-
graded during both the early and late phases. Consistent
with a role for BRAT in both translational repression
F1
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carrying BRAT-binding sites is subject to both forms of
regulation. An in vivo role for BRAT in mRNA degrad-
ation was verified by an analysis of the transcriptome
of embryos lacking functional BRAT protein, which re-
vealed that BRAT mediates the degradation of hun-
dreds of maternal mRNAs during the MZT, as part of
both the ‘early’ and ‘late’ decay machineries. Taken to-
gether, our results provide the first insights into
BRAT’s role as a global regulator of mRNA decay dur-
ing the MZT via direct binding to a large number of
maternal transcripts.
Results and discussion
Genome-wide identification of BRAT- and PUM-associated
mRNAs in early Drosophila embryos
To identify BRAT- and PUM-associated mRNAs in
early Drosophila embryos we performed RNA co-
immunoprecipitations followed by microarray analysis
(RIP-Chip). For the immunoprecipitations, we first gener-
ated synthetic antibodies against BRAT and PUM using
phage display approaches (see Methods). We have previ-
ously demonstrated that such antibodies, expressed and
purified from E. coli as antigen-binding fragments (Fabs),
can be used in RIP experiments to identify RBP-associated
mRNAs [32,33]. After confirming the ability of these anti-
bodies to immunoprecipitate BRAT and PUM by west-
ern blot (Additional file 1), we carried out RIP-Chip
experiments using extracts prepared from wild-type
embryos collected 0 to 3 h post egg-laying. Associated
mRNAs were defined as those that, across three bio-
logical replicates, had a false discovery rate (FDR) of
less than 5% and an average enrichment of at least 1.5-
fold in the BRAT or PUM RIP-Chips compared to
negative control RIP-Chips using synthetic antibody
C1 [32,33].
mRNAs corresponding to 1,197 genes and 641 genes
were found to be associated with BRAT and PUM, re-
spectively (Figure 1A and B; Additional files 2 and 3).
We refer to these associated mRNAs as BRAT ‘targets’
and PUM ‘targets’. hb mRNA, previously defined as both
a PUM and BRAT target mRNA in early embryos, was
on both target lists, while bicoid mRNA, which has been
identified as a PUM target [34], was on the PUM but
not on the BRAT list. Cyclin B mRNA, a third well-
characterized target of PUM [3,23,24,35], just missed the
cutoff for the PUM-target list (1.4-fold enriched in the
PUM RIP compared to the negative control, with an
FDR <10%) and was not on the BRAT list. In addition to
regulating hb mRNA in early embryos, BRAT has been
reported as a putative post-transcriptional repressor of
other mRNAs in different tissues [22,30,36]. One of
these, dMyc, is expressed in 0 to 3 h embryos and was
also on our BRAT list. Finally, 300 (47%) of our PUM-bound mRNAs overlapped with a list of transcripts pre-
viously identified to be associated with transgenically
expressed PUM-RBD in whole ovaries [37] (Fisher’s
exact test P value <10−109) (Additional file 4). Together
these data lend confidence to our lists of BRAT- and
PUM-associated mRNAs.BRAT and PUM are associated with largely non-overlapping
sets of mRNAs
To define the extent to which PUM and BRAT share tar-
gets we compared our lists of associated mRNAs. As de-
scribed earlier, cooperation between BRAT and PUM has
been demonstrated in the case of translational repression
of hb mRNA as well as a number of other transcripts and,
although BRAT-independent functions for PUM and
PUM-independent functions for BRAT have been identi-
fied, the extent to which PUM and BRAT cooperate glo-
bally is unknown. Of the 1,197 BRAT-associated mRNAs
and 641 PUM-associated mRNAs that we identified, 200
were found to be associated with both RBPs, a statistically
significant overlap (Fisher’s exact test P value <10−13;
Figure 1C). Comparison of our BRAT-associated mRNAs
to those identified as targets of transgenically expressed
PUM-RBD in whole ovaries [37] yielded similar results:
a statistically significant overlap of 190 mRNAs (Fisher’s
exact test P value <0.01; Additional file 4). Eighty-six
mRNAs were in common between the BRAT-bound,
PUM-bound, and PUM-RBD-bound lists. Together,
these results support the hypothesis that a significant
number of target RNAs are co-regulated by BRAT and
PUM.
Despite the statistically significant overlap of PUM-
targets and BRAT-targets, the majority of BRAT-targets
were not bound by PUM and vice versa. To assess
whether this might constitute evidence that BRAT and
PUM also function independently of each other in early
embryos, we examined the correlation between the fold-
enrichments of mRNAs in the BRAT RIP-Chip versus
the PUM RIP-Chip. Strikingly, the vast majority of
BRAT-associated mRNAs showed no evidence of being
associated with PUM, and the vast majority of PUM-
associated mRNAs showed no evidence of being associ-
ated with BRAT (Figure 1D). Indeed, if we removed from
consideration the transcripts that were enriched in the
control RIP in both experiments (and therefore tend to
correlate since the same negative control was used in both
cases), there was a strong and statistically significant nega-
tive correlation between the fold-enrichments of the
remaining mRNAs (Figure 1D; Spearman’s rho = −0.188,
P value <10−37). This is the opposite of what would be
expected if the two proteins primarily bind together,
clearly demonstrating that BRAT and PUM are most
often found associated with different target mRNAs.
Figure 1 BRAT and PUM each associate with hundreds of mRNAs in early Drosophila embryos. (A) BRAT associates with mRNAs from 1,197
genes, and (B) PUM associates with mRNAs from 641 genes. Plots show RMA-normalized signal intensity of all transcripts represented on the
microarray that were defined as expressed in early embryos, in BRAT RIP or PUM RIP versus Control RIP. Values represent averages from three
independent biological replicates. mRNAs with an average enrichment of at least 1.5-fold in the BRAT or PUM RIPs and with an FDR <5%
are highlighted in blue or red, respectively. The solid diagonal line represents no enrichment, and dashed diagonal lines represent 1.5-fold
enrichment or depletion. (C) Venn diagram demonstrating that there is a modest but statistically significant overlap between BRAT-associated
and PUM-associated mRNAs. **Fisher’s exact test P value <10−13. (D) Plot of all transcripts represented on the microarray that were defined as
expressed in early embryos, showing fold-enrichment in the BRAT RIP-Chip versus the PUM RIP-Chip. Transcripts associated exclusively with BRAT
or PUM (that is, enriched >1.5-fold with an FDR <5%) are highlighted in blue and red, respectively, and transcripts associated with both BRAT
and PUM are highlighted in green. Note that the majority of BRAT-associated transcripts show no indication of enrichment in the PUM RIP-Chip,
and vice versa; this is further indicated by the negative Spearman’s correlation between the fold-enrichments from the two experiments when
transcripts which are enriched in the control in both experiments (that is, the bottom left quadrant of the plot) and therefore expected to be
correlated given that the same control was used in both cases, are excluded: Spearman’s rho = −0.188, P <10−37.
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BRAT-associated mRNAs
To identify the RNA cis-element(s) recognized by PUM
and BRAT in vivo, an algorithm we developed previ-
ously [38] was used to search for any short contiguoussequences that are predicted to be accessible to binding
and that are enriched in PUM or BRAT target mRNAs
compared to negative control sets of co-expressed





Laver et al. Genome Biology  (2015) 16:94 Page 5 of 30Analysis of our list of PUM-associated mRNAs yielded
a motif, UGUANAKW (N=A/C/G/U; K =U/G; W=A/U)
(Figure 2A) with a mean area under the receiver-operating
characteristic (AUROC) of 0.78 on held-out data (see
Methods for information on AUROCs and details of the
cross-validation procedure, and Additional file 5 for the
results). This motif is nearly identical to the previously
reported PUM binding motif [5,15,16,37,39] and con-
tains the invariant ‘UGUA’ sequence found among the
binding sites of multiple PUF-family proteins from a
variety of species [40]. Our de novo discovery of the
known PUM binding motif strongly validates our list of
PUM-associated mRNAs.
Motif discovery applied to our list of BRAT-
associated mRNAs predicted a motif with the consensus
‘NNUGUUDNN’ (D = A/G/U) (Figure 2B) with a mean
AUROC of 0.75 on held-out data (see Methods for details
of the cross-validation procedure and Additional file 5 for
the results). BRAT has recently been shown to directly
associate with hb RNA, and its binding site has been
mapped to the sequences in and around the hb NRE
Box A [17]. Notably, our BRAT motif is a perfect match
for the Box A site of the second hb NRE if the residues
upstream of the Box A site are included (UUGUUGU;
Figure 2C). In contrast, the Box A site of the first hb
NRE lacks the first U found within the core UGUU of
our motif (Figure 2C). These differences correlate with
the reported differential behavior of the two NREs
in vitro and in vivo: in vitro, the BRAT NHL domain
binds more efficiently to the second hb NRE than the
first, while in S2 cell reporter assays the Box A site of
the second NRE is required for BRAT-mediated transla-
tional repression, whereas the Box A site of the first
NRE has a negligible contribution to this repression
[17]. Similarly, the NRE-like sequence in cyclin B, whichFigure 2 PUM- and BRAT-binding motifs. (A) Motif enriched among PUM-
enriched among BRAT-associated mRNAs, identified by de novo motif disco
mRNAs with the sequences of the ‘Box A’ motifs from the two hb NREs an
repression by BRAT, but the Box A motifs from hb NRE1 and the cycB NRE
RNAcompete using purified GST-BRAT-NHL domain.lacks the core UGUU sequence of our BRAT motif, in-
teracts with and functions through PUM and NOS, but
not BRAT [3]. Taken together, these data strongly sup-
port the conclusion that the consensus motif identified
by our computational analysis is likely to be the bona
fide BRAT recognition site in vivo.
We next asked whether the consensus motifs we iden-
tified for PUM and BRAT tended to be present in the 5′
untranslated region (UTR), open reading frame (ORF),
or 3′UTR of their target transcripts. To address this, we
determined the AUROC for each consensus motif within
each of these regions of the target transcripts compared
to co-expressed non-targets. For both PUM and BRAT,
their consensus motif was highly enriched in the 3′
UTRs of their targets (Figure 3A and B; AUROC = 0.79).
There was, in contrast, lower enrichment of the consen-
sus motifs in either the 5′UTRs or ORFs (Figure 3A and
B; AUROC = 0.55-0.65). A similar result was observed
when we analyzed only those transcripts that are co-
targets of both BRAT and PUM (Figure 3C and D). This
indicates that both PUM and BRAT bind primarily to
the 3′UTRs of their target transcripts.
Finally, to assess our conclusion that BRAT and PUM
primarily regulate different sets of transcripts, we
assessed enrichment of the consensus motifs among tar-
gets bound by BRAT and PUM together, PUM only, or
BRAT only. We found that the consensus PUM motif is
highly enriched in the PUM and BRAT co-targets
(AUROC = 0.84) as well as in the PUM-only targets
(AUROC = 0.82), but is much less strongly enriched in
the targets that were associated with BRAT only
(AUROC = 0.60) (Figure 4A). Similarly, the consensus
BRAT motif was highly enriched in the PUM and BRAT
co-targets (AUROC = 0.84) as well as in the BRAT-only
targets (AUROC = 0.79), but much less strongly in theassociated mRNAs, identified by de novo motif discovery. (B) Motif
very. (C) Comparison of the motif enriched among BRAT-associated
d the cycB NRE. Note that the Box A motif from hb NRE2 mediates
do not (see text). (D) In vitro BRAT-binding motif determined by
Figure 3 PUM and BRAT motifs are primarily enriched in the 3’UTRs of their associated mRNAs. AUROCs were calculated to determine the
enrichment score of the PUM and BRAT motifs computationally determined from the RIP-Chip data in 5’UTRs, ORFs, and 3’UTRs of target
transcripts. Assessment of the enrichment of (A) the BRAT motif among all BRAT targets, (B) the PUM motif among all PUM targets, (C) the BRAT
motif among the subset of BRAT-PUM co-targets, and (D) the PUM motif among the subset of BRAT-PUM co-targets.
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results support the conclusion that, while BRAT and
PUM do co-associate with a subset of transcripts, they
primarily bind different sets of mRNAs.
Interestingly, in this regard, the pum mRNA is high on
the list of PUM targets (fold-enrichment = 20.5, FDR =
0%) and the brat mRNA is high on the list of BRAT tar-
gets (fold-enrichment = 6.2, FDR = 0%) but pum mRNA
is not on the list of BRAT targets (fold-enrichment = 1.1,
FDR =NA) and brat mRNA is not on the list of PUM
targets (fold-enrichment = 1.04, FDR = 46%). We specu-
late that PUM and BRAT autoregulate their own, but
not one another’s, mRNAs.
In vitro identification of the spectrum of BRAT-binding
sites
To complement the computational motif finding analysis
of the BRAT targets identified by RIP-Chip, we assessed
the spectrum of sites that are bound by BRAT in vitrousing the RNAcompete assay [39,41]. This assay involves
the incubation of a GST-tagged RBP or RBD of interest
with an excess of a complex pool of approximately
240,000 30-41mer RNAs that contains at least 16 copies
of each 9mer sequence and at least 310 copies of each
7mer. After capture of the protein on glutathione resin,
co-purifying RNAs are identified using microarrays,
allowing one to assess the binding specificity of the RBP.
Applying this approach to the BRAT NHL domain,
which is BRAT’s RBD, we identified a motif that is very
similar to the one we defined through computational
motif finding applied to our RIP-Chip data: this RNA-
compete motif has a core consensus UGUUA with a
strong preference for a U residue both before and after
the core (Figure 2D and Additional file 6). Taken together
with our computational analysis of BRAT-associated
mRNAs these data provide strong evidence that BRAT
directly binds RNA, both in vitro and in vivo, through a
motif carrying a core UGUU sequence.
F5
Figure 4 Enrichment of PUM and BRAT motifs among associated
mRNAs. (A) AUROC plots showing how well the PUM motif
determined from our RIP-Chip data distinguishes the following sets
from co-expressed non-targets: BRAT and PUM co-targets, BRAT-only
targets (BRAT not PUM targets), and PUM-only targets (PUM not
BRAT targets). (B) AUROC plots showing how well the BRAT motif
determined from our RIP-Chip data distinguishes the following sets
from co-expressed non-targets: BRAT and PUM co-targets, BRAT-only
targets (BRAT not PUM targets), and PUM-only targets (PUM not
BRAT targets). (C) AUROC plots showing how well the presence of a
BRAT motif alone (as determined from our RIP-Chip data), a PUM
motif alone (as determined from our RIP-Chip data), either a BRAT or
a PUM motif (Either motif), or both a BRAT and a PUM motif
(Both motifs), distinguish the set of BRAT and PUM co-targets from
co-expressed non-targets.
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tissue culture cells
To assess the functional significance of the predicted
BRAT-binding motif in vivo we used Drosophila S2 tis-
sue culture cells in which we expressed luciferase re-
porter mRNAs carrying either an array of six wild-type
or an array of six point-mutated BRAT-binding sites in
their 3′UTRs (Figure 5A). The reporter with the wild-
type array was repressed 2.2-fold relative to the reporter
with the mutant array (Figure 5B, Student’s t test P <0.001).
To verify that the observed repression was, indeed, medi-
ated by BRAT, we carried out RNAi-mediated knockdown
of BRAT (Additional file 7). Strikingly, repression
was completely abrogated upon knockdown of BRAT
(Figure 5C, Student’s t test P <0.01). We conclude
that the BRAT-binding motif defined on the basis of our
computational analysis of BRAT-bound transcripts as well
as in vitro using RNAcompete, is indeed bound by BRAT
in vivo, and mediates repression of the bound targets.
Co-targets of PUM and BRAT contain binding sites for
both RBPs
While our results indicate that PUM and BRAT largely
function separately in mRNA regulation, there was a sta-
tistically significant overlap between their sets of target
transcripts (Fisher’s exact test P value <10−13; Figure 1C).
For this set of co-targets, the co-occurrence of the PUM
and BRAT motifs had a similar predictive value (AUROC=
0.86) to the presence of either a PUM or a BRAT motif
(AUROC= 0.90), and the presence of each motif alone
(PUM motif AUROC= 0.84 and BRAT motif AUROC=
0.84) (Figure 4C). Thus, the PUM-BRAT co-targets have
binding sites for both proteins, suggesting that they are
directly bound by both RBPs and excluding models
where either PUM or BRAT is indirectly recruited to
these mRNAs via an interaction with the other protein.
We note, however, that these results do not rule out the
possibility that PUM and BRAT cooperate in the recog-
nition of their co-targets. Indeed, in vitro experiments
Figure 5 BRAT represses expression of reporter transcripts in S2 cells. (A) Schematic of luciferase reporters containing the Firefly luciferase ORF
fused to a 3’UTR carrying either six wild-type (luc-wt) or six mutated (luc-mut) BRAT-binding sites. (B) Luciferase activity from each of the
reporters was measured after transfection into S2 cells, and normalized to a Renilla luciferase control. Luciferase activity was reduced to
approximately 40% by the wild-type sites compared to the mutated sites. (C) Normalized luciferase activity (Firefly/Renilla) from the luc-wt
reporter relative to the luc-mut reporter was measured upon treatment with either control dsRNA or one of two dsRNAs directed against brat
(Additional file 7 quantifies BRAT knockdown). RNAi-mediated knockdown of brat abrogated repression of the luc-wt reporter, resulting in an
approximately three-fold increase in expression of the luc-wt reporter relative to the mutated reporter. (D) Normalized luciferase mRNA levels
(Firefly/Renilla) from the luc-wt reporter relative to the luc-mut reporter were measured by RT-qPCR upon treatment with control dsRNA or
either of the two dsRNAs directed against brat. The steady state level of the luc-wt reporter was approximately 75% that of the mutated
reporter, indicating that BRAT-binding sites reduce steady-state RNA levels. RNAi-mediated knockdown of brat abrogated this repression,
resulting in an approximately two-fold increase in expression of the wild-type reporter relative to the mutated reporter. Comparing the results
in (C) and (D), both the repression of the wild-type reporter relative to the mutated reporter and the increase in expression of the wild-type
reporter upon BRAT knockdown, were less for steady state mRNA levels (D) than for luciferase activity (C), indicating that BRAT regulates both
mRNA stability and translational repression. Values represent average of three biological replicates (B and C) or two biological replicates (D)
and error bars indicate standard deviation. Student’s t-test P values are indicated.
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finity of the BRAT RBD for the hb NREs, and vice versa
[17].T1
Functional analysis of all PUM-associated mRNAs
To gain insights into the biological and molecular pro-
cesses regulated by PUM and BRAT, we asked whether
our PUM- and BRAT-associated mRNAs are enriched
for any particular functions. To assess this, we per-
formed gene annotation enrichment analysis for our lists
of PUM and BRAT target mRNAs using the DAVID
functional annotation tool [42,43]. For this analysis, an-
notation terms enriched with a Benjamini P value of less
than 0.1 or an FDR of less than 10% were consideredsignificant, as in our previous analyses of the targets of
Staufen (STAU) [33] and Smaug (SMG) [44].
Analysis of the entire set of PUM-associated mRNAs
revealed enrichment for a number of developmental, cel-
lular, and molecular functions (Table 1; Additional file 8).
First, PUM-associated mRNAs were highly enriched for
functions related to pattern formation, cell fate commit-
ment, and morphogenesis during early embryogenesis.
For instance, Gene Ontology (GO) terms such as ‘embry-
onic pattern specification’, ‘axis specification’, ‘blastoderm
segmentation’, and ‘embryonic morphogenesis’ were highly
enriched among PUM-associated mRNAs, consistent with
previously reported analysis of transcripts associated with
transgenically expressed PUM-RBD [37]. Our PUM-
associated mRNAs that fell into these categories included















Embryonic pattern specification +++ ++ . . .
Axis specification ++ . + . +
Embryonic morphogenesis/gastrulation ++++ +++ . . .
Formation of organ boundary ++++ ++++ . . .
Imaginal disc development/pattern formation ++++ +++ . . .
Oogenesis/ovarian follicle cell development ++ + . . .
Neuroblast fate determination + . . . +
Tube development/digestive system
development/respiratory system development
++ + . . .
Salivary gland development + + . . .
Sensory organ development +++ ++ . . .
Cellular
Cell motility/cell migration +++++ +++ . . +
Neuron projection morphogenesis +++ ++ . . .
Cell division/asymmetric cell division + + . . .
Cell adhesion + + . . .
Regulation of growth/cell size ++ ++ . . .
Regulation of apoptosis + . . . .
Molecular
Signal transduction +++++ ++++ + . +++
Regulation of transcription ++++ +++ . . +
Protein kinase activity ++ . + . .
Phosphatase activity . . + . .
Glycosyltransferase ++ + . . .
Integral membrane proteins ++++ + +++++ +++ +++
Glycoproteins +++ ++ . . .
Ion transport/homeostasis . . +++ ++ +
Phospholipid/phosphoinositide metabolism . . +++ +++ .
+ FDR = 1% to 10%; ++ FDR = 0.1% to 1%; +++ FDR = 0.001% to 0.1%; ++++ FDR = 10−5% to 0.001%; +++++ FDR <10−5%; ‘.’ = not significant (FDR >10% and
Benjamini P value >0.1). FDR values represent the most significantly enriched annotation term related to the function listed. Analyses were performed using the
DAVID functional annotation tool [42,43]. For details see Additional file 8.
Laver et al. Genome Biology  (2015) 16:94 Page 9 of 30ones with known roles in both anterior-posterior and
dorsal-ventral axis formation in oocytes and early embryos
(for example, oskar (osk), nos, bicoid (bcd), caudal (cad),
pum itself, gurken (grk), cactus (cact), easter (ea), swallow
(sw), tolloid (tld)), as well as mRNAs from gap genes, pair-
rule genes, and segment polarity genes and their regula-
tors (for example, knirps (kni), Kruppel (Kr), hunchback
(hb), caudal (cad), sloppy paired 1 (slp1), even skipped
(eve), cubitus interruptus (ci), frizzled 3 (fz3), brother of
tout-velu (botv)). Moreover, PUM targets included
mRNAs coding for Polycomb and trithorax group pro-
teins (for example, Polycomb (Pc), Posterior sex combs
(Psc), female sterile (1) homeotic (fs(1)h), Enhancer of
bithorax (E(bx))), which regulate the transcription of thehomeotic genes, as well as regulators of homeotic gene ac-
tivity (for example, homothorax (hth), teashirt (tsh)), and
regulators of gastrulation (for example, folded gastrulation
(fog)).
Taken together these results suggest that PUM’s role
in pattern formation and morphogenesis during embryo-
genesis may extend beyond its well-characterized role in
posterior patterning via translational repression of ma-
ternally derived hb mRNA. In support of this conclusion
are reported defects in anterior development, including
defects in head involution and mouth hook formation,
which have been attributed to PUM’s regulation of
bicoid mRNA at the anterior of the embryo [34]. Indeed,
our analysis of the cuticles of embryos produced by
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pumMsc [45-47], showed severely defective body pattern,
including reduced or absent head skeleton (96%) and
lack of both thoracic and abdominal segments (100%)
(n = 23). With regard to these observed defects, it is in-
teresting to note that ‘head segmentation’ is one of the
pattern formation-related GO terms enriched among
our list of PUM targets and includes the genes homo-
thorax (hth), even skipped (eve), sloppy paired 1 (slp1),
teashirt (tsh), fushi tarazu (ftz), hb, and jing.
In addition to these roles in embryonic pattern forma-
tion, PUM-associated mRNAs were enriched for GO
terms related to pattern formation and morphogenesis
during a variety of developmental processes that occur
outside of the time window analyzed by our RIP-Chip.
Such enriched GO terms included ‘oogenesis’, ‘formation
of organ boundary’, ‘imaginal disc development’, ‘tube
morphogenesis’, ‘gland development’, ‘sensory organ de-
velopment’, and ‘neuroblast fate commitment’. As we
have discussed previously for STAU [33] this, in part, re-
flects the fact that many of the genes and pathways that
are involved in early embryonic processes are re-utilized
later in development (for instance, 23 out of 50 genes
annotated with the GO term ‘imaginal disc development’
are also annotated with GO terms related to embryonic
pattern formation and morphogenesis). We therefore
speculate that PUM may have important roles at a var-
iety of developmental stages through the regulation of
the same target mRNAs.
PUM-associated mRNAs were also enriched for a
number of cellular-level functions. These included GO
terms related to cell movement, such as ‘cell motion’ and
‘cell motility’. PUM has, indeed, been implicated in a
variety of cell motility-related processes. For example,
PUM has an essential role in primordial germ cell mi-
gration in embryos [23] and 35 of the 47 listed mRNAs
coding for proteins with roles in cell motility are
expressed in primordial germ cells. Six of these 35 have
been classified as enriched in primordial germ cells [48],
including polar granule component (pgc), nos, and modi-
fier of mdg4 (mod(mdg4)), all of which have also been
specifically implicated in germ cell migration. PUM’s
regulation of these transcripts may also contribute to its
involvement in cell motility-related processes in other
tissues. For instance, PUM has been shown to regulate
dendritogenesis in the larval peripheral nervous system
[49], and the GO terms ‘neuron projection morphogenesis’,
‘dendrite morphogenesis’, and ‘axonogenesis’ are all
enriched among PUM targets.
PUM targets were also enriched for the GO terms ‘cell
division’ and ‘asymmetric cell division’. PUM’s regulation
of these mRNAs may contribute to the role of PUM in
primordial germ cell mitosis, germ-line stem cell divi-
sions [50], and the regulation of early nuclear divisionsthroughout the early embryo [35]. In addition, PUM tar-
gets were enriched for GO terms related to regulation of
cell size and organism growth, as well as apoptosis.
These targets included Insulin-like receptor (InR), Akt1,
Pten, Target of rapamycin (Tor), and p53.
At the molecular level, PUM’s target mRNAs encoded
proteins that were highly enriched for signal-transduction-
related GO terms, such as ‘cell surface receptor linked sig-
nal transduction’ and ‘protein kinase activity’. Enrichment
of these categories is consistent with analysis of transcripts
associated with transgenically expressed PUM-RBD [37].
Our PUM-associated mRNAs included ones encoding
components of a variety of signal transduction pathways:
Jak-STAT, Notch, Wnt, insulin receptor, and MAPK sig-
naling. With respect to MAPK signaling, PUM has re-
cently been shown to regulate multiple components of the
EGFR signaling pathway [51]. Our data may reflect a fairly
general role for PUM in regulation of signal transduction.
PUM-associated mRNAs were also highly enriched for
functions in ‘regulation of transcription’, including ones
that encode transcriptional activators and repressors
belonging to a number of families: HMG proteins,
homeobox proteins, basic helix-loop-helix proteins,
and Forkhead-family proteins. Also notable is the
mRNA encoding Zelda/Vielfaltig (VFL), which is re-
quired for high-level activation of a subset of the zygotic
genome [52-54]. Together, a role for PUM in regulation of
signal transduction and transcription may reflect the
mechanisms by which it regulates the developmental pro-
cesses listed above.
Finally, PUM-associated mRNAs were enriched for
GO terms such as ‘intrinsic to membrane’. This is, again,
consistent with analysis of mRNAs associated with
transgenically expressed PUM-RBD [37]. The products
of our PUM-associated mRNAs localize to the plasma
membrane and a variety of intracellular and organelle
membranes. Particularly enriched were glycoproteins,
glycosyltransferases, and proteins related to proteoglycan
biosynthesis, suggesting a role for PUM in regulating
glycoprotein synthesis and function.Functional analysis of all BRAT-associated mRNAs
We next performed gene annotation enrichment analysis
on the entire set of BRAT-associated mRNAs (Table 1;
Additional file 8). Several enriched GO terms overlapped
with those enriched among PUM-bound mRNAs, includ-
ing ‘axis specification’, ‘intracellular signaling cascade’, and
‘protein kinase activity’. Enrichment for genes with func-
tions in axis specification is consistent with the fact that
embryos produced by brat-mutant females have defects in
abdominal segmentation [3], and suggests that misregula-
tion of mRNAs in addition to hb may contribute to this
phenotype.
T2
Laver et al. Genome Biology  (2015) 16:94 Page 11 of 30BRAT targets were also enriched for mRNAs encoding
membrane proteins, as indicated by enrichment of GO
terms such as ‘intrinsic to membrane’, again similar to
PUM. Indeed, this was the most highly enriched GO
term among BRAT-associated mRNAs, and their encoded
proteins localize to both the plasma membrane (68 genes
were annotated with the GO term ‘plasma membrane’)
and the membranes of a variety of organelles (73 genes
were annotated with the GO term ‘organelle membrane’),
including those of the endoplasmic reticulum, mitochon-
dria, Golgi, nucleus, lysosome, and peroxisome. A particu-
larly enriched subclass of these proteins, represented
among BRAT-associated mRNAs but not PUM-associated
mRNAs, is involved in ion transport, including ion chan-
nels, ATP-dependent ion transporters, and ion exchange
factors.
In addition to membrane proteins themselves, BRAT
target mRNAs were highly enriched for those encoding
proteins that regulate the lipid component of mem-
branes, as exemplified by enrichment for GO terms such
as ‘phospholipid metabolic process’ and ‘phosphoinositide
metabolic process’. These included a number of enzymes
involved in fatty acid biosynthesis and phospholipid bio-
synthesis, as well as enzymes involved in the addition of
glycophosphatidylinositol (GPI) anchors onto membrane-
associated proteins. In addition, they included regulators
of phosphoinositide signaling - both phosphatidylinositol
kinases and phosphatidylinositol phosphatases.
Functional analysis of mRNAs associated with both PUM
and BRAT
Given that a number of related GO terms were enriched
among both PUM and BRAT-associated mRNAs, we
next asked whether any of these functions might be spe-
cifically regulated by PUM and BRAT acting together.
To address this, we performed additional gene annota-
tion enrichment analyses on the sets of mRNAs that
were associated with: (1) PUM only; (2) BRAT only; and
(3) both PUM and BRAT (Table 1; Additional file 8).
This revealed that most of the enriched GO terms asso-
ciated with all PUM targets were also enriched among
the PUM-only targets. Similarly, the majority of the
enriched GO terms associated with all BRAT targets
were also enriched when one considered those mRNAs
bound by BRAT only. These results suggest that most of
the functions of PUM and BRAT can be regulated inde-
pendently of one another. There are, however, notable
exceptions, discussed below.
First, GO terms related to ‘neuroblast differentiation’
were significantly enriched among the set of BRAT-
PUM co-targets. These GO terms were not enriched
among the PUM-only or BRAT-only lists. Five BRAT-
PUM co-targets were annotated with this term, includ-
ing three of the four transcription factors that comprisethe achaete-scute complex (achaete (ac), scute (sc), and
lethal of scute (l(1)sc)), which have an important role in
specifying neuroblast fate, as well as hb and jumeau
(jumu). Although our RIPs were performed on embryonic
stages prior to the formation of neuroblasts, this is par-
ticularly interesting given the well-characterized function
of BRAT in regulating neuroblast differentiation. Taken
together these data suggest a cooperative role for PUM
and BRAT in neuroblast differentiation through regulation
of the aforementioned transcripts.
Second, the GO terms ‘axis specification’, ‘zygotic de-
termination of anterior/posterior axis, embryo’, and
‘signal transduction’ were enriched among BRAT-PUM
co-targets. Several similar or identical terms were enriched
among the PUM-only targets but not among the BRAT-
only targets. This is consistent with the possibility that
these functions are regulated by BRAT and PUM
cooperatively.Analysis of the localization of PUM- and BRAT-associated
mRNAs
We next analyzed the localization patterns of the differ-
ent classes of target transcripts in order to define spatial
aspects of PUM and BRAT function. To do so we used
the localization pattern annotations in the Fly-FISH
database [55,56]. Annotation terms and localization pat-
terns enriched with an FDR of less than 10% were con-
sidered significant, as in our previous analyses of the
targets of STAU [33] and SMG [44].
PUM-associated mRNAs were enriched for a variety of
localization patterns (Table 2; Additional file 9). For ex-
ample, PUM targets were highly enriched for transcripts
localized to the ‘posterior’ and to the ‘pole plasm’ during
embryonic stages 1 to 3. This is consistent with the re-
quirement for PUM for normal primordial germ cell mi-
gration and mitosis, processes that PUM may control
through post-transcriptional regulation of these posterior-
localized mRNAs. PUM targets were also enriched for
mRNAs with ‘perinuclear’ (at stages 1 to 3) and ‘cell div-
ision apparatus’ (at stages 4 to 5) localization patterns.
These enrichments may reflect PUM’s role in cell division
in a variety of contexts, as discussed above. BRAT-
associated mRNAs, like PUM-associated mRNAs, were
significantly enriched for genes with ‘posterior’ localization
patterns, as well as ‘perinuclear’ localization (Table 2;
Additional file 9).
Consistent with a role for PUM in regulation of pat-
tern formation through control of zygotically transcribed
mRNAs, PUM targets were also significantly enriched
for both zygotically transcribed transcripts, generally,
and ‘gap-gene’ localization patterns, in particular. In

















Embryonic stages 1 to 3 localization patterns
Posterior localization + . ++ . ++
Nuclei-associated/Perinuclear + . ++ . ++
Embryonic stages 4 to 5 localization patterns
Segmented/Gap-gene localization +++ +++ . . .
Patterns indicative of zygotic transcription +++++ ++++ . . +
Perinuclear around yolk nuclei + + . . .
Cell division apparatus + + . . .
Apical enrichment + + . . .
Pole cell enrichment . . + . .
Yolk plasm localization . . . + .
+ FDR = 1% to 10%; ++ FDR = 0.1% to 1%; +++ FDR = 0.001% to 0.1%; ++++ FDR = 10−5% to 0.001%; +++++ FDR <10−5%; ‘.’ = not significant (FDR >10%). FDR
values indicated represent the most significantly enriched term related to the localization pattern listed. For details see Additional file 9.
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also applied to PUM-only, BRAT-only, and/or PUM-
BRAT co-target mRNAs (Table 2; Additional file 9). ‘Ap-
ical’, ‘cell division apparatus’, and ‘gap-gene’ localization
patterns, as well as ‘zygotically transcribed’ transcripts in
general, remained significantly enriched among PUM-
only transcripts but not BRAT-only or PUM-BRAT co-
targets. However, ‘perinuclear’ and ‘posterior localization’
were enriched among the PUM and BRAT co-targets
but not among the PUM-only or BRAT-only targets.
This enrichment for posterior localization suggests that
BRAT may contribute to some of PUM’s functions in
the development of pole cells.
Since both PUM and BRAT are ubiquitous whereas
NOS is posterior localized, we speculate that NOS pro-
vides spatial specificity to the co-regulated transcripts, as
is the case for hb mRNA. In support of this idea, a mu-
tation in NOS has been shown to affect the recruitment
of BRAT to the second hb NRE in vitro and translational
repression of hb in vivo, without affecting either NOS or
PUM association with the NRE [3], suggesting that NOS
may stabilize BRAT’s interaction with the PUM-BRAT
co-targets.
BRAT- and PUM-associated mRNAs are translationally
repressed and degraded during the maternal-to-zygotic
transition
To gain further insight into how PUM and BRAT function
to regulate their target transcripts, we took advantage of
previously published genome-wide datasets that defined
the translational status or stability of mRNAs in early
Drosophila embryos. We first assessed the efficiency with
which PUM and BRAT target mRNAs are translated in
early embryos. To do this, we made use of our publisheddata that employed polysome gradients followed by
microarray analysis to define, genome-wide, the efficiency
with which mRNAs are translated in wild-type 0- to 2-
hour-old embryos (Chen et al., [44]). This was accom-
plished by calculating the ‘translation index’ for each
mRNA by dividing the amount of that mRNA that is
polysome-associated, and therefore likely to be translated,
by the amount that is not polysome-associated, and thus
not being translated [44]. We found that the translation
indices of both PUM and BRAT target mRNAs were sig-
nificantly lower than the translation indices of all of the
transcripts assayed in our RIP experiments (Figure 6A;
Table 3). This is consistent with the known roles of both
PUM and BRAT as translational repressors. To further as-
sess this conclusion, we also compared our target mRNAs
to lists of mRNAs defined as ‘translationally active’ or
‘translationally inactive’ in 0- to 2-hour-old embryos by a
second, independent, genome-wide polysome gradient-
microarray study (Qin et al., [57]). Again consistent with
its role as a repressor, BRAT-associated mRNAs signifi-
cantly overlapped with the list of translationally inactive
transcripts and were significantly depleted of translation-
ally active transcripts (Table 3; Additional file 10). PUM
targets were not significantly correlated with translational
repression based on this comparison (Table 3; Additional
file 10).
The subsets of transcripts bound only by BRAT or
only by PUM had significantly lower translation indices
as defined by Chen et al. [44] than the set of all
expressed transcripts (Figure 6A; Table 3). Transcripts
associated only with BRAT significantly overlapped with
Qin et al.’s [57] translationally inactive transcripts and
were depleted of translationally active transcripts (Table 3;
Additional file 10). These results suggest that BRAT and
Figure 6 BRAT- and PUM-associated mRNAs are translationally repressed, and BRAT-associated mRNAs are degraded during the MZT. (A) Boxplots
depicting the translation indices from wild-type 0 to 2 h embryos [44] for all expressed transcripts (that is, all transcripts found to be expressed in
our 0 to 3 h embryos used for the RIP-Chip experiments), BRAT non-target transcripts, PUM non-target transcripts, all BRAT target transcripts,
BRAT-not-PUM target transcripts (that is, all BRAT targets excluding BRAT-PUM co-targets), all PUM target transcripts, PUM-not-BRAT target
transcripts (that is, all PUM targets excluding BRAT-PUM co-targets), and BRAT-and-PUM co-target transcripts. A higher translation index indicates
more actively translated mRNAs. The dotted line represents the median translation index of all expressed transcripts detected in our 0 to 3 h RIP
input embryo lysate. (B) Boxplots depicting the proportion of RNA present in 2 to 4 h embryos compared to 0 to 2 hour embryos, according to
modENCODE RNAseq data available on FlyBase, for the same sets of transcripts described in (A). Note that outliers (that is, transcripts for which
the value is greater than 1.5 times the interquartile distance higher or lower than the upper or lower quartiles, respectively) are not shown to
allow the y-axis to be magnified around the median values. The dotted line represents the median for all expressed transcripts detected in our 0
to 3 h RIP input embryo lysate. For both (A) and (B) Wilcoxon Rank Sum tests were performed to determine the significance of the differences
between BRAT and PUM targets compared to ‘All expressed transcripts’: *P <0.01, **P <10−5, ***P <10−27.
Laver et al. Genome Biology  (2015) 16:94 Page 13 of 30PUM are able to mediate translational repression inde-
pendent of one another. Not surprisingly, BRAT and PUM
co-targets were also significantly correlated with transla-
tional repression by comparison to both datasets [44,57]
(Figure 6A; Table 3; Additional file 10).
We next asked whether we could detect any relationship
between PUM or BRAT binding and mRNA stability dur-
ing the MZT in early embryos. For this analysis, we made
use of a number of previously published datasets: from De
Renzis et al. [58] and Thomsen et al. [59], which defined
the entire set of maternal transcripts that are degraded
during the MZT; from Fly-FISH [55,56], which annotates
transcripts that are degraded at specific developmental
stages; from modENCODE RNAseq, which measured
transcript levels in embryos at various developmental
stages, including embryos collected 0 to 2 h versus 2 to
4 h post egg-laying; and from Thomsen et al. [59] and
Tadros et al. [60], which defined whether transcripts that
are degraded during the MZT are cleared by maternally
encoded (‘early’) and/or zygotically encoded (‘late’) decay
machineries.
Our list of PUM-associated mRNAs was significantly
enriched for unstable maternal mRNAs as defined by
Thomsen et al. [59] (Table 3; Additional file 10). Inaddition, PUM-associated mRNAs were significantly
enriched for transcripts annotated as ‘Degraded completely
stage 5’ in the Fly-FISH database (Table 3; Additional file
9). Our PUM-associated transcripts were not enriched for
ones eliminated by the early decay machinery, as defined
in [59,60] (Table 3; Additional file 10). In contrast, our sets
of PUM-associated mRNAs, of PUM-only targets, and of
PUM-BRAT co-targets were significantly enriched for
transcripts degraded by the late decay machinery (as de-
fined by [59]). Moreover, the PUM-only transcripts were
significantly enriched for ones annotated as ‘Degraded
completely stage 5’ in the Fly-FISH database (Table 3;
Additional files 9 and 10). These results are consistent
with Thomsen et al.’s analysis of mRNAs associated with
transgenically expressed PUM-RBD [37], which led them
to conclude that PUM-RBD-bound transcripts undergo
late decay. Taken together, our data are consistent with
the hypothesis that PUM plays a role in mRNA degrad-
ation late during the MZT [58,59].
While PUM has previously been predicted to be in-
volved in mRNA decay [59], there has heretofore been no
evidence of a role for BRAT in mRNA destabilization.
Strikingly, however, BRAT-associated mRNAs were very
highly enriched for maternal transcripts that are degraded












PUM and BRAT co-
target mRNAs
Translational repression
Lower than expected translation index
Chen et al., 2014 [44]a +++ ++ +++++ ++++ +++
Enriched for translationally inactive
mRNAs
Qin et al., 2007 [57]b . . +++ +++ .
Depleted of translationally active
mRNAs
Qin et al., 2007 [57]b . . ++++ ++++ +
mRNA degradation
Degraded in early embryos:
De Renzis et al., 2007 [58]b . . ++++ ++++ .
Thomsen et al., 2010 [59]b +++ . +++++ +++++ +++
Fly-FISH database c + + +++ +++ .
Degraded from 0 to 2 h to 2 to 4 h
(modENCODE RNAseq)a
. . +++++ +++++ .
Degraded via maternal degradation
machinery
Tadros et al., 2007 [60]b . . ++++ ++++ .
Thomsen et al., 2010 [59]b . . +++ +++ .
Degraded via zygotic degradation
machinery
Thomsen et al., 2010 [59]b +++ + +++ +++ +++
+ P = 0.01 to 0.05; ++ P = 0.001 to 0.01; +++ P = 10−10 to 0.001; ++++ P = 10−10 to 10−30; +++++ P <10−30; ‘.’ = not significant.
aP values are Wilcoxon Rank Sum test. Also see Figure 6.
bP values are Benjamini-Hochberg corrected Fisher’s exact test (that is, FDR). For complete details of comparisons see Additional file 10.
cP values are Benjamini-Hochberg corrected Fisher’s exact test (that is, FDR). For details of comparisons see Additional file 9.
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Thomsen et al. [59] (Table 3; Additional file 10), as well as
transcripts degraded during stages 4 to 5 as defined by the
Fly-FISH database (Table 3; Additional file 9). Moreover,
analysis of the modENCODE RNAseq data revealed that,
for BRAT targets, the amount of RNA present in 2 to 4 h
versus 0 to 2 h embryos is significantly lower than for
the entire set of genes assayed in our RIP-Chip data
set (Figure 6B; Table 3). Unlike PUM, BRAT targets
were enriched for mRNAs degraded by both the early
decay machinery as defined in both Thomsen et al.
[59] and Tadros et al. [60], and the late decay machin-
ery [59] (Table 3; Additional file 10). Notably, all of
these enrichments were also true for the BRAT-only
subset of mRNAs (Figure 6B; Table 3; Additional files
9 and 10).
Taken together, these data strongly suggest that, in
addition to its role as a translational repressor, BRAT
has an important PUM-independent function in mRNA
destabilization during the MZT, acting as a component
of both the early and the late decay machineries. Furthersupporting a role for BRAT in decay is the previously re-
ported enrichment of a UUGUU motif among unstable
maternal mRNAs [58], which carries the UGUU core of
our BRAT consensus motif. Combined with the strong
enrichment for unstable transcripts among our BRAT-
associated mRNAs, these results lead to the prediction
that BRAT is a regulator of transcript degradation dur-
ing the MZT.
BRAT reduces mRNA translation and stability in S2 tissue
culture cells
As a first step towards assessing the possible role of
BRAT in mRNA decay, we used the S2 tissue culture
cell luciferase reporter assay described above (Figure 5A).
RT-qPCR showed that the steady-state level of tran-
scripts carrying the array of six wild-type BRAT-binding
sites was lower than that of transcripts carrying the array
of six point-mutated BRAT-binding sites (Figure 5D,
Control RNAi), consistent with a role for BRAT in pro-
moting mRNA degradation. This effect on the reporter
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creased more than two-fold upon RNAi-mediated BRAT
knockdown (Figure 5D, brat RNAi 1 and 2). Comparison
of the data in Figures 5C and D suggests that BRAT
also translationally represses its targets as, upon BRAT
knockdown, there was a greater increase in luciferase
enzyme activity (approximately three-fold) than in lu-
ciferase mRNA levels (approximately two-fold). These
results are consistent with a role for BRAT in both
translationally repressing and inducing the degradation
of its targets.
BRAT-associated mRNAs are stabilized in embryos from
brat-mutant females
In light of the predicted novel function of BRAT in
mRNA decay during the MZT we next used microarrays
to globally compare the transcriptome of 0- to 1.5-, 1.5-
to 3-, 3- to 4.5-, and 4.5- to 6-h-old embryos from brat-
mutant females (referred to henceforth as ‘brat mutant
embryos’) to wild-type embryos at the same stages. This
resulted in the identification of 1,182 genes whose tran-
script levels were significantly higher and 1,022 genes
whose transcript levels were significantly lower in brat
mutants than wild type at one or more time points (FDR
<5%; Figure 7A to D; Additional file 11).
If BRAT has a role in mRNA decay, one would expect
that the genes that are upregulated in brat mutant em-
bryos would be direct targets of BRAT. Indeed, there was
a highly significant overlap between BRAT-associated
mRNAs as defined by our RIP-Chip experiment and tran-
scripts upregulated in brat mutant embryos at 1.5 to 3.0,
3.0 to 4.5, and 4.5 to 6.0 h (Figure 7B to D, Table 4,
Bonferroni-corrected Fisher’s exact test P values ranged
from 6.6 × 10−12 to 5.7 × 10−20). Moreover, the 3′UTRs of
the upregulated transcripts were significantly enriched for
BRAT-binding sites relative to co-expressed transcripts
whose expression level was unchanged in brat-mutant
embryos (Table 4, AUROC values ranged from 0.56 to
0.59; Bonferroni-corrected WMW Rank Sum P values
ranged from 0.016 to 6.1 × 10−6; Additional file 12). Taken
together, these data strongly suggest that the upregulation
of transcripts at 1.5 to 3.0, 3.0 to 4.5, and 4.5 to 6.0 h is a
direct consequence of the absence of BRAT binding.
In contrast, at the 0- to 1.5-h time point, there was no
significant overlap between the BRAT-associated mRNAs
and those upregulated in bratmutant embryos (Figure 7A,
Table 4, Bonferroni-corrected Fisher’s exact test P = 1) and
the 3′UTRs of these transcripts were not enriched for
BRAT-binding sites (AUROC= 0.52; Bonferroni-corrected
WMW Rank Sum P = 1; Table 4; Additional file 12), sug-
gesting that the upregulation of these transcripts at the
first time point is not a direct result of BRAT binding and
may, instead, be due to secondary effects associated with
the brat mutant phenotype. Our analysis of the transcriptsthat were downregulated in brat mutant embryos also
suggested they are not direct BRAT targets (Table 4,
Additional file 12).BRAT promotes degradation of maternal mRNAs via both
the early and late decay machineries
Having demonstrated that BRAT-associated mRNAs are
upregulated in brat mutant embryos, we next assessed
the expression dynamics of the upregulated genes using
k-means clustering [61,62]. This method subdivided the
upregulated transcripts into six distinct classes based
solely on their expression in wild-type embryos (Figure 8,
Additional files 13 and 14). These six classes can be
loosely divided into two subsets. The first subset in-
cludes Classes A, B, and C, which consist of transcripts
that start out at relatively high levels at the 0- to 1.5-h
time point and are degraded subsequently (Figure 8A to
C; Additional file 14), suggesting that these classes largely
comprise maternally expressed transcripts that are de-
graded during the MZT. Indeed, comparison of Class A,
B, and C transcripts to previously published datasets
[58-60] revealed that virtually all are maternally deposited
and that Classes B and C are significantly depleted of zyg-
otically transcribed mRNAs, while Class A appears to rep-
resent maternally-expressed mRNAs that are degraded
and then re-expressed upon zygotic genome activation
(Table 5; Additional file 15). The second subset includes
Classes D, E, and F, which consist of transcripts that in-
crease in abundance between the 0- to 1.5-h and the 1.5-
to 3.0-h time points (Figure 8D to F; Additional file 14),
suggesting that they primarily comprise transcripts that
are expressed upon zygotic genome activation. Consistent
with this, they are highly enriched for zygotically
expressed transcripts, and Classes D and E are signifi-
cantly depleted of maternally expressed transcripts
(Table 5; Additional file 15).
To understand the nature of BRAT’s potential role in
their regulation, we assessed the enrichment of BRAT-
associated mRNAs (as defined by our RIP-Chip experi-
ment) in each expression class. Strikingly, this revealed
that each of Classes A, B, and C were very significantly
enriched for BRAT-associated mRNAs, suggesting that
these mRNAs are direct BRAT targets (Table 5; Add-
itional file 15). In contrast, Classes D, E, and F were not
enriched for BRAT-associated mRNAs, suggesting that
their upregulation is likely to result from indirect effects
of the brat mutant phenotype (Table 5; Additional file
15). The segregation of BRAT-associated mRNAs into
Classes A through C is especially impressive when one
considers that the six classes were generated through
analysis of the expression of these transcripts only in
wild-type embryos. Together, these data strongly support
a major role for BRAT in directly regulating the
Figure 7 (See legend on next page.)
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Figure 7 BRAT-associated mRNAs are globally upregulated in brat-mutant embryos. Scatterplots of RMA-normalized signal intensity in brat
mutant versus w1118 embryos at (A) 0 to 1.5 h, (B) 1.5 to 3.0 h, (C) 3.0 to 4.5 h, and (D) 4.5 to 6.0 h post egglaying. Plots show all transcripts
represented on the microarray that were defined as expressed (see Methods). Values represent averages from three independent biological
replicates. The solid diagonal line represents no enrichment. Transcripts up or down in brat mutant embryos compared to wild-type embryos with
an FDR <5% were defined as up- or downregulated transcripts, and are highlighted with orange and magenta, respectively. Beside each plot are
Venn diagrams depicting the overlap between transcripts upregulated at the corresponding timepoint and the set of BRAT-associated mRNAs
defined by our RIP-Chip (also see Table 4). Note that these comparisons suggest that the transcripts upregulated at 1.5 to 3.0, 3.0 to 4.5, and 4.5
to 6.0 h are directly regulated by BRAT as they are enriched for BRAT-associated mRNAs. In contrast, those upregulated at 0 to 1.5 h likely reflect
changes resulting from secondary effects of the brat mutation. The total number of BRAT-associated transcripts (890) shown in this figure and
Figure 8 differs from the number in Figure 1 (1,197) because of differences in the set of expressed genes defined for these two experiments. We
only considered the subset of BRAT targets identified in Figure 1 that were also defined as expressed in the brat-mutant time-course shown here.
Likewise, in the Venn diagrams in this figure and in Figure 8 the numbers of transcripts upregulated in brat mutants differ from the numbers in
the associated plots. **P <10−11 (Bonferroni-corrected Fisher’s exact test).
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MZT.
A closer examination of the expression patterns of the
transcripts present in Classes A through C suggests that
BRAT functions in both early and late decay pathways,
as our earlier analysis of BRAT-associated mRNAs had
predicted. In wild-type embryos, Class C transcripts
remained stable through the first two time points, but
were degraded by the 3.0- to 4.5-h time point, indicating
decay through a late pathway. In contrast, Class A and B
mRNAs decreased between the 0- to 1.5-h and the 1.5-
to 3.0-h time points, suggesting decay through an early
pathway. Whether Class A and B mRNAs are also de-
graded via late pathways is unclear. The rate of decrease
of mRNAs in Class B was constant between the 0- to
1.5-h and 3.0- to 4.5-h time points suggesting that they
are not also attacked by a late-acting machinery; how-
ever it remains possible that a maternal machinery act-
ing on these mRNAs is replaced by one that acts
zygotically. The expression of Class A mRNAs increased
in wild type at the 3.0- to 4.5-hour time point, indicating
that these genes are also zygotically transcribed; this pre-
vented us from determining whether Class A mRNAs
are also subject to degradation via a late pathway. We
note that Class A transcripts significantly overlap with
those previously defined [59] as degraded via ‘maternal
only’ and ‘maternal plus zygotic’ pathways; Class B tran-
scripts with ‘maternal plus zygotic’ and ‘zygotic only’
pathways; and Class C transcripts with ‘zygotic only’Table 4 Summary of comparisons to BRAT-associated mRNAs a
up- or downregulated in brat mutant embryos
Upregulated in brat mutan
0-1.5 h 1.5-3 h 3-4
Overlap with BRAT-associated mRNAsa . ++++ ++
Enrichment of BRAT-binding sites in 3’UTRb . +++ ++
(+) or (−) P = 0.01 to 0.05; (++) or (− −) P = 0.001 to 0.01; (+++) or (− − −) P = 10−10
overlap or enrichment, (−) symbols indicate significant non-overlap or depletion; ‘.’
aP values are Bonferroni-corrected Fisher’s exact test. For complete details of compa
bP values are Bonferroni-corrected WMW P values. For complete details of comparispathways (Table 5). These overlaps are consistent with
our assessment of the expression patterns of these differ-
ent classes, and support the conclusion that BRAT pro-
motes mRNA degradation via both early and late decay
pathways.Maternally loaded hb mRNA is stabilized in embryos
lacking functional BRAT protein
Prior to our transcriptome-wide analyses reported here,
the hb mRNA was the only known direct target of
BRAT, which was shown to repress a luciferase-hb 3′
UTR reporter mRNA in S2 cells [17]. Our RIP-Chip ex-
periments have shown that hb mRNA co-purifies with
BRAT in early embryos. It therefore was of particular
interest to ask whether BRAT is required for degradation
of maternal hb transcripts, in addition to the well-
established role for BRAT in translational repression of
hb mRNA. Since hb transcripts are loaded maternally
(the hb-RB mRNA isoform) as well as synthesized zygot-
ically (the hb-RA mRNA isoform), and the probes on
our microarray did not distinguish between these iso-
forms, we carried out RT-qPCR with maternal-hb-spe-
cific (hb-RB) primers to assess whether it was stabilized
in embryos produced by brat-mutant females. Consist-
ent with a role for BRAT in destabilizing the maternal
transcripts, hb-RB was present at significantly elevated
levels in brat mutant compared to wild-type embryos,
particularly at the 1.5- to 3-h and 3- to 4.5-h time pointsnd of BRAT-binding motif enrichment tests for transcripts
t embryos Downregulated in brat mutant embryos
.5 h 4.5-6 h 0-1.5 h 1.5-3 h 3-4.5 h 4.5-6 h
++ ++++ . . - - - - - -
+ + . - - - - - - - - - -
to 0.001; (++++) or (− − − −) P = 10−10 to 10−22; (+) symbols indicate significant
= not significant (that is, P >0.05).
risons see Additional file 12.
ons, including AUROCs, see Additional file 12.
Figure 8 (See legend on next page.)
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Figure 8 BRAT promotes decay of maternally expressed mRNAs during the MZT via both the early and late decay machineries. K-means
clustering analysis of the union of transcripts upregulated at any time point in brat mutant embryos partitioned transcripts into six classes on the
basis of their expression in wild-type embryos. (A-F) Plots showing the average expression levels (RMA-normalized signal intensity) of the
transcripts in each class, in wild-type (solid line) and brat mutant (dashed line) embryos, from 0 to 6 h post egg-laying. Below each plot are Venn
diagrams depicting the overlap of the transcripts in each class with the set of BRAT-associated mRNAs defined by our RIP-Chip. These comparisons
indicate that Classes A, B and C are significantly enriched for BRAT-associated mRNAs and therefore are likely to be direct targets of BRAT. In contrast,
Classes D, E and F show no enrichment for BRAT-associated mRNAs, and are therefore likely upregulated as a result of secondary effects of the brat
mutation. Given that Classes A, B, and C comprise maternally-expressed transcripts that undergo decay during the MZT, via the early (Classes A and B)
and late (Class C) machineries (see text and Table 5), their stabilization in brat mutants indicates a role for BRAT in decay of maternal mRNAs during
the MZT through both the early and late decay machineries. *P <10−6, **P <10−18 (Fisher’s exact test).
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tional repression and degradation of maternal hb mRNA.
Analysis of the functions and localization patterns of
mRNAs stabilized in brat mutants
We next asked whether any particular annotated func-
tions or localization patterns were enriched among tran-
script Classes A, B, and C. Strikingly, the GO terms
enriched in these three classes were nearly identical to
those enriched among the entire set of BRAT-associated
mRNAs and included ‘intrinsic to membrane’, ‘ion trans-
port’, ‘phosphate metabolic process’, ‘Jak-STAT signaling’,
‘embryonic pattern specification’, and terms related to lipid
and glycerophospholipid metabolism (Table 6; Additional
file 16). A small number of GO terms, however, were
enriched among the stabilized transcripts but not among
the set of BRAT-associated mRNAs (for example, ‘starch
and sucrose metabolism’). Localization patterns enriched
among the stabilized mRNAs included posterior and pole-
cell localization as well as perinuclear localization, again
consistent with those we had found to be enriched among
BRAT-associated mRNAs (Table 7; Additional file 17).
The fact that the annotated functions and localization
patterns enriched among Classes A, B, and C so closely
matched those enriched among the set of BRAT-associated
mRNAs further supports our conclusion that these three
classes of transcripts largely represent direct targets of
BRAT.
Expression of Zelda (Vielfaltig) target genes is
misregulated at early time points in brat mutant embryos
As described above, Classes D through F largely comprise
zygotically expressed transcripts that are upregulated in
brat mutants in a manner not directly dependent on
BRAT. This led us to ask whether misexpression of any of
the transcription factor mRNAs bound by BRAT could ex-
plain their upregulation. The mRNA encoding Zelda
(VFL), which is essential for normal zygotic genome acti-
vation [52-54], was strongly associated with BRAT in our
RIP-Chip experiments (5.1-fold enriched, FDR = 0%). We,
therefore, asked whether any of the upregulated tran-
scripts in Classes D, E, and F correspond to genes previ-
ously defined as Zelda (VFL) targets. Strikingly, all threeclasses were significantly enriched for transcripts encoded
by genes whose promoters have been shown to be directly
bound by Zelda (VFL) as assayed via ChIP-Seq [52]
(Table 5; Additional file 15). There was a similar enrich-
ment among Classes D and F, but not Class E, for tran-
scripts previously shown to be downregulated in zelda
(vfl) mutant embryos [53] (Table 5; Additional file 15).
In brat-mutant embryos transcripts in Classes D, E,
and F are upregulated at the 0- to 1.5-h time point, which
overlaps with the phase where Zelda/VFL is known to
bind its target genes and activate their transcription
[52-54]. We therefore hypothesize that, in wild-type em-
bryos, the BRAT RBP represses the zelda (vfl) mRNA. In
bratmutant embryos, then, Zelda (VFL) would be upregu-
lated, leading to upregulation of its target genes (for ex-
ample, hb [54]; Additional file 18 shows the effect on
zygotically transcribed hb in brat mutants). Consistent
with this model is the fact that increasing the number of
Zelda (VFL) binding sites in a Zelda (VFL) target gene re-
sults in earlier transcription of that gene [63,64]. In
addition, while the zelda (vfl) mRNA is bound by BRAT,
we did not detect a change in zelda (vfl) mRNA levels in
brat mutant embryos. Thus, BRAT is likely to regulate the
zelda (vfl) mRNA at the level of translation. However, with
respect to upregulation of Zelda’s target genes, we cannot
exclude the possibility that BRAT also regulates either the
stability or the translation of mRNAs encoding co-factors
of Zelda.
The role of other trans-acting factors in BRAT-dependent
mRNA decay
SMG has previously been identified as a major regulator of
maternal mRNA elimination via a maternally encoded, early
decay pathway in the embryo [60] while the miR-309 cluster
of miRNAs, which is expressed zygotically, has been shown
to act via a late pathway [65,66]. Comparisons of the mRNAs
in Classes A, B, and C with mRNAs that require either SMG
or the miR-309 cluster for their degradation showed no sig-
nificant overlap (Table 5; Additional file 15), suggesting that
BRAT does not cooperate with SMG or the miR-309 miR-
NAs in transcript degradation. BRAT-mediated mRNA deg-
radation may therefore represent a novel pathway for both
early and late transcript decay during the MZT. BRAT has
Table 5 Summary of comparisons of the six classes of transcripts upregulated in brat mutant embryos to other
datasetsa
Class A Class B Class C Class D Class E Class F
BRAT-associated mRNAs
(as defined in this study)
All BRAT targets +++ ++++ +++ . . .
BRAT-not-PUM targets +++ ++++ +++ - - . .
BRAT-and-PUM co-targets . + + + . .
Maternally- vs. zygotically-expressed transcripts
Maternally-expressed transcripts
Tadros et al., 2007 [60] . . +++ - - - - - - - - .
De Renzis et al., 2007 [58] . ++ + - - - - - - - - - - .
Thomsen et al., 2010 [59] . +++ +++ - - - - - - - - - - .
Zygotically-expressed transcripts
De Renzis et al., 2007 [58] +++ - - - - - - - ++++ + .
Thomsen et al., 2010 [59] - - - - - - - - - - - +++++ ++++ ++
Maternally-expressed and degraded transcripts
Maternally-expressed and degraded in early embryos
De Renzis et al., 2007 [58] ++++ ++++ - - - - - - - . - - - -
Thomsen et al., 2010 [59] ++++ ++++ . - - - - . - - - -
Maternally-expressed and degraded in unfertilized eggs
Tadros et al., 2007 [60] +++ ++++ - - - - - - - . - - -
Degraded exclusively via early decay machinery
Thomsen et al., 2010 [59] + . - - - - . .
Degraded via early and late decay machineries
Thomsen et al., 2010 [59] +++ ++++ - - - - - - . - - - -
Degraded exclusively via late decay machinery
Thomsen et al., 2010 [59] . +++ ++++ - - . .
Cooperation with other trans-acting factors in mRNA degradation
Smaug-dependent unstable mRNAs
Tadros et al., 2007 [60] . - - - . - - - - .
miR-309 cluster-dependent unstable mRNAs
Bushati et al., 2008 [65] . . . - . .
Zelda transcriptional targets
Bound by Zelda in promoter region by ChIP-Seq
Harrison et al., 2011 [52]
Nuclear cycle 8 . . . ++++ . ++
Nuclear cycle 13 . . . ++++ . +
Late nuclear cycle 14 . . - ++++ + .
Downregulated in zelda mutant embryos
Liang et al., 2008 [53] . . . ++ . +++
(+) or (−) P = 0.01 to 0.05; (++) or (− −) P = 0.001 to 0.01; (+++) or (− − −) P = 10−10 to 0.001; (++++) or (− − − −) P = 10−10 to 10−30; (+++++) or (− − − − −) P <10
−30; (+) symbols indicate significant overlap or enrichment, (−) symbols indicate significant non-overlap or depletion; ‘.’ = not significant (that is, P >0.05). P values
are Benjamini-Hochberg corrected Fisher’s exact test (that is, FDR). For complete details of comparisons see Additional file 15.
aWe note that transcripts that were downregulated in brat mutant embryos at the 1.5- to 3.0-h and 4.5- to 6.0-h time points were also modestly enriched for
mRNAs produced by direct targets of Zelda [52] (Benjamini-Hochberg corrected Fisher’s exact test P = 0.016 and 0.032, respectively) and those downregulated at
1.5 to 3.0 h were strongly enriched for genes downregulated in zelda-mutant embryos [53] (Benjamini-Hochberg corrected Fisher’s exact test P = 6.6 × 10−9). We
speculate that increased Zelda expression in 0 to 1.5 h brat-mutant embryos disrupts the normal cascade of zygotic genome activation resulting in
downregulation of a subset of Zelda’s targets at the later time points.
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Figure 9 Maternally expressed hb mRNA is stabilized in brat-mutant
embryos. Levels of the maternally expressed isoform of hb mRNA
(hb-RB) were assayed by RT-qPCR in brat mutant or wild-type
embryos collected 0 to 1.5, 1.5 to 3.0, 3.0 to 4.5, and 4.5 to 6.0 h post
egg-laying, and normalized to levels of RpL32 mRNA, whose levels
are stable throughout this time-course. hb mRNA levels were significantly
higher in brat mutant than wild-type embryos at 1.5 to 3.0, 3.0 to 4.5,
and 4.5 to 6.0 h (values represent average of three biological replicates
+/− standard error of the mean). *P <0.05, **P <0.005 (Student’s t-test).
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NOT1 subunit of the CCR4/NOT deadenylase complex
[67], suggesting that BRAT, like SMG [68], may induce tran-
script decay through a mechanism that involves deadenylase
recruitment to target transcripts.
PUM-RBD-bound mRNAs are enriched in those de-
graded late [59] and we have shown here that PUM-Table 6 Comparison of gene annotation enrichment analyses












Neuroblast fate determination . .
Cellular
Cell motility/cell migration . .
Molecular
Signal transduction + .
Regulation of transcription . .
Protein kinase activity + .
Phosphatase activity + .
Integral membrane proteins +++++ +++




+ FDR = 1% to 10%; ++ FDR = 0.1% to 1%; +++ FDR = 0.001% to 0.1%; ++++ FDR =
Benjamini P value >0.1). FDR values represent the most significantly enriched annot
DAVID functional annotation tool [42,43]. For details see Additional files 8 and 16.associated mRNAs immunoprecipitated with our syn-
thetic anti-PUM Fab are enriched for maternal transcripts
that undergo late decay. Since a subset of BRAT-
associated mRNAs also undergoes late decay, our data
suggest that BRAT-mediated late decay could involve
cooperation with PUM. As discussed earlier, Class C
BRAT-dependent mRNAs are unambiguously degraded
through a late pathway. Interestingly, we observed a
significant overlap of Class C mRNAs with those co-
associated with both PUM and BRAT (but not with
PUM-only targets) (Table 5; Additional file 15), sug-
gesting that PUM and BRAT are likely to cooperate in
late decay of their shared target transcripts.
Conclusions
Here we have shown that PUM and BRAT each bind to
hundreds of mRNAs in early Drosophila embryos. Our data
suggest that BRAT and PUM recognize a relatively small
proportion of co-targets whereas the majority of targets are
bound only by BRAT or only by PUM. Thus, BRAT and
PUM function largely independently. Through computa-
tional analysis of PUM- and of BRAT-associated transcripts,
we have identified the previously known PUM motif and a
novel consensus motif for BRAT binding in vivo that is dis-
tinct from the PUM motif. The motif we identified for
in vivo-bound transcripts is almost identical to one that we
identified in vitro using RNAcompete. This represents the







in brat mutant embryos
Class A Class B Class C
+ . . +
+ . . .
+ . . .
+++ . . +
+ . . .
. . . +
. . . +
+++ . + .
+ . +++ .
. . + .
10−5% to 0.001%; +++++ FDR <10−5%; ‘.’ = not significant (FDR >10% and
ation term related to the function listed. Analyses were performed using the
Table 7 Comparison of Fly-FISH localization patterns enriched among BRAT-associated mRNAs and mRNAs upregulated











mRNAs upregulated in brat mutant embryos
Class A Class B Class C
Embryonic stages 1 to 3 localization patterns
Posterior localization ++ . ++ . . .
Nuclei-associated/Perinuclear ++ . ++ . . ++++
Embryonic stages 4 to 5 localization patterns
Patterns indicative of zygotic
transcription
. . + . . .
Pole cell enrichment + . . . +++ +
Yolk plasm localization . + . . . .
+ FDR = 1% to 10%; ++ FDR = 0.1% to 1%; +++ FDR = 0.001% to 0.1%; ++++ FDR = 10−5% to 0.001%; +++++ FDR <10−5%; ‘.’ = not significant (FDR >10%). FDR
values indicated represent the most significantly enriched term related to the localization pattern listed. For details see Additional files 9 and 17.
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onstrating that it confers BRAT-dependent repression on
luciferase reporter mRNAs in S2 tissue culture cells.
Analysis of the functions of PUM- and BRAT-
associated mRNAs identified a variety of novel roles for
the post-transcriptional regulatory activity of these RBPs in
early embryos. For PUM, these include a wider than previ-
ously appreciated role in embryonic pattern formation as
well as a role in cell motility and post-transcriptional regu-
lation of mRNAs encoding transcription factors, signal
transduction components and membrane proteins. In con-
trast, BRAT plays a role largely in the post-transcriptional
regulation of mRNAs encoding membrane proteins and
proteins functioning in membrane-related processes.
Both PUM- and BRAT-associated mRNAs are translated
at low levels, consistent with their previously known roles
as translational repressors. We also assessed a potential role
for PUM and BRAT in regulating mRNA stability during
the MZT. While analysis of the identified target RNAs sug-
gests that PUM’s role is primarily in late, zygotically
encoded decay, BRAT is predicted to function in both early
and late decay. Consistent with these correlations we have
shown that BRAT-mediated repression in Drosophila tissue
culture cells occurs at the level of both translational repres-
sion and mRNA destabilization. A global role for BRAT in
mRNA decay during the MZT was demonstrated by time-
course microarray analysis of brat-mutant embryos in
which hundreds of BRAT targets were stabilized. These
data are consistent with BRAT being an important compo-
nent of both early and late decay machineries during the
Drosophila MZT, and representing a novel pathway for
both early and late mRNA decay.
Methods
Drosophila stocks
Drosophila stocks used were as follows: w1118, bratfs1/
CyO [69], and Df(2L)TE37C-7/CyO [70]. The bratfs1mutation results in a G774D amino acid substitution
in the NHL domain that causes female sterility
[3,27,69]. The G774D mutation causes defects in RNA-
binding [17].Generation and purification of anti-BRAT and anti-PUM
synthetic antibodies
Synthetic antibodies were generated against antigens
comprising BRAT amino acids 375–565 (numbering ac-
cording to BRAT-PA isoform), and PUM amino acids
726–882 (numbering according to PUM-PA isoform),
each expressed and purified from E. coli as GST fusion
proteins, as described [32]. Five rounds of binding selec-
tion with synthetic antibody Library F [71] were per-
formed against GST-BRAT375–565 and GST-PUM726–882
coated on 96-well Maxisorp Immunoplates (NUNC,
Rochester, NY, USA) as described [72]. Each round in-
cluded negative selection to remove GST binders from
the phage pool, through pre-incubation of phage with
purified GST, either immobilized on 96-well Maxisorp
Immunoplates by coating overnight at 4°C at a concen-
tration of 5 μg/mL (rounds 1 to 2), or in solution at a
concentration of 0.5 mg/mL (rounds 3 to 5). After five
rounds of selection, phage were produced from indi-
vidual clones and used in phage ELISAs to identify
clones that bound the RBP antigen but not GST, as de-
scribed [72]. Such clones were submitted to DNA se-
quencing to identify unique Fabs.
The two synthetic antibodies used in this study, anti-
BratA1 Fab and anti-Pum7 Fab, were then expressed
and purified from E. coli as FLAG- and 6xHis-tagged
Fabs, as described [32].Immunoprecipitations
Extract was prepared from embryos collected 0 to 3 h
post egg-laying. Embryos were disrupted in a minimal
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KOH (pH 7.4), 1 mM MgCl2, 1 mM DTT, protease in-
hibitors (1 mM AEBSF, 2 mM benzamidine, 2 μg/mL
pepstatin, 2 μg/mL leupeptin). After centrifugation, the
supernatant was recovered and stored at −80°C.
For RIP-Chip experiments, 400 μL of embryo extract
was supplemented with Triton X-100 to 0.1%, then di-
luted in an equal volume of lysis buffer with 0.1% Triton
X-100. This diluted extract was re-centrifuged, and incu-
bated for 3 to 4 h at 4°C with 40 μL of anti-FLAG M2
affinity gel (Sigma) carrying 20 μg of purified FLAG-
tagged Fab and blocked with BSA. Beads were washed
four times with cold wash buffer A (lysis buffer plus
0.1% Triton X-100), and three times with cold wash buf-
fer B (100 mM NaCl, 100 mM HEPES-NaOH (pH 7.4),
1 mM MgCl2). Fabs and associated protein and RNA
were then eluted from the beads by one 20 min elution
at 4°C with 100 μL of FLAG-peptide (Sigma; 200 μg/mL
in wash buffer B), and RNA was isolated from the eluate
using TRI Reagent (Sigma).
For immunoprecipitations for western blot, immuno-
precipitations were carried out as above but at a smaller
scale, using 50 μL of initial embryo extract, 5 μL of anti-
FLAG M2 affinity gel carrying 2.5 μg of purified FLAG-
tagged Fab, and eluting with 25 μL of FLAG peptide.
SDS-PAGE sample buffer was then added to eluate for
western blot analysis (see Additional file 1).
Microarray analysis of BRAT and PUM RIP samples
For microarray analysis of RIP samples, double-stranded
cDNA was prepared following the protocol described in
the NimbleGen Array User’s Guide (Gene Expression
Arrays, version 6.0), but using a primer mixture contain-
ing 50 ng/μL random hexamer primers and 67 pmol/μL
anchored-oligo-dT primers. Specifically, double-stranded
cDNA was prepared from 150 ng or 200 ng of immuno-
precipitated RNA. 400 or 500 ng of double-stranded
cDNA was labelled with Cy3- or Cy5-tagged random
nonamers following the Roche NimbleGen protocol. La-
belled cDNA was then hybridized to custom-designed
Drosophila 4 × 72 K NimbleGen arrays (GEO platform
number: GPL10539): each array was hybridized with
1 μg each of one Cy3- and one Cy5-labelled IP-RNA-
derived sample, and washed, according to the NimbleGen
protocol. Three biological replicates each were performed
for anti-BRAT, anti-PUM, and control immunoprecipi-
tated samples. Arrays were scanned with a GenePix4000B
microarray scanner system (Molecular Devices, Inc., Sun-
nyvale, CA, USA). Scanned images were initially quanti-
fied using Nimblescan (Roche) and the resulting data were
normalized using the ArrayStar 3 (DNASTAR) software
using the RMA quantile method. BRAT and PUM immu-
noprecipitation samples were each normalized along with
the control, separately.To identify BRAT- or PUM-associated mRNAs, micro-
array data were analyzed using the Significance Analysis
of Microarrays (SAM) [73] function available in the
MultiExperiment Viewer software application [61,62].
Prior to performing SAM analysis, data from the immu-
noprecipitation samples were filtered such that only the
subset of transcripts which we previously defined as
expressed in 0- to 3-h embryos [33] was analyzed. Note
that total RNA isolated from input embryo extract for
the BRAT and PUM RIPs was also analyzed by micro-
array and determined to be very highly correlated with
this previous analysis of transcript expression in 0- to 3-
h embryos (data not shown). The normalized microarray
signal intensities in the anti-BRAT or anti-PUM immu-
noprecipitations were then compared to the normalized
microarray signal intensities in the control immunopre-
cipitations for all transcripts in the expressed set, using
SAM two-class paired analysis. Genes significantly
enriched in the anti-BRAT or anti-PUM immunoprecipi-
tates compared to the control immunoprecipitate, with
an FDR of less than 5% and at least 1.5-fold enrichment,
were defined as BRAT- or PUM-associated mRNAs. The
co-expressed non-targets used in the motif discovery
and analysis of translation index and RNAseq data were
those that were defined as expressed but which were
negatively enriched in the ‘two-class paired analysis’
(that is, enriched in the control RIPs) for either the anti-
BRAT or anti-PUM RIPs.
For the purposes of all subsequent analyses, gene IDs
were updated to the most recent version (FlyBase release
5.56) by taking the FlyBase FBgn IDs present in the array
gene description file and updating them using the ‘Upload/
Convert IDs’ tool available on FlyBase.
Motif discovery
The BRAT and PUM motifs were identified using the
#ATS model, as described [38]. Briefly, the #ATS model
is a discriminative de novo motif discovery algorithm,
which takes as input positive (that is, bound or target
transcripts) and negative (that is, co-expressed unbound
or non-target transcripts) gene lists, and outputs the
RNA motif that best distinguishes the positive and nega-
tive transcripts by having more accessible motif matches
among the bound transcripts. Initial motif discovery was
carried out on the relevant entire gene list. Then, to as-
sess the predictive power of the motif(s), we calculated
AUROC scores using a 3 × 10 cross-validation proced-
ure. Specifically, we randomly split the positive and
negative sets into 10 equal size bins, trained the motif
using 9 of 10 bins (that is, the training set) and evaluated
the predictive power of the motif on the remaining bin
(that is, the test set). We repeated this procedure three
times to avoid potential bias in the splitting procedure,
and finally collected 30 test set AUROCs.
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the difference of medians between two distributions. Sig-
nificance is assigned to an AUROC using a Wilcoxon-
Mann–Whitney rank sum test. A perfect AUROC of 1.0
would indicate that motif scores of all targets are higher
than scores of all co-expressed non-targets. Thus, as ex-
amples, an AUROC of 0.8 means that, on average, tar-
gets have motif scores that are higher than those of 80%
of the co-expressed non-targets, indicating enrichment
of the motif; an AUROC of 0.5 means that, on average,
targets have motif scores that are no different from those
of co-expressed non-targets; and an AUROC of 0.4
means that, on average, targets have motif scores that
are higher than 40% (that is, lower than 60%) of the co-
expressed non-targets, indicating depletion of the motif.
Motif enrichment tests on target transcripts and
transcripts with altered levels in brat mutants
To evaluate the enrichment of a motif in the positive set
versus the negative set, we assigned each transcript a
score equal to the sum of the accessibilities of the motif
matches in the transcript, and then used the AUROC
score to evaluate how well that score distinguished
bound and co-expressed unbound transcripts. The tran-
scripts without a motif match were assigned a score of
zero. The same strategy was used to evaluate motif
enrichment (AUROC >0.5) or depletion (AUROC <0.5)
in transcripts whose expression changed significantly in
brat-mutant embryos relative to wild-type embryos,
using co-expressed transcripts whose levels were un-
changed as the control set (see below).
Source of transcript sequences for motif finding
The Drosophila melanogaster (BDGP5.4) transcript se-
quences were downloaded from Ensembl using BioMart
[74]. When there were multiple isoforms for a gene, we
used the longest isoform to represent the gene.
Quantifying target site accessibility for motif finding
Target site accessibility was assessed using RNAplfold.
We fixed W = 80 and L = 40 and set U to the width of
the motif, as previously described [38]. When calculating
target site accessibilities for a 5′UTR, ORF, or 3′UTR
site, we input the entire transcript into RNAplfold to en-
sure that the target site accessibility for sites immediately
around the start codon or the stop codon was calculated
correctly.
Analysis of BRAT RNA-binding using RNAcompete
The RNA pool generation, RNAcompete pulldown as-
says, and microarray hybridizations were performed as
previously described [39,41]. Briefly, GST-tagged BRAT
NHL domain (amino acids 756–1037 of Drosophila
BRAT isoform A as defined by Flybase) (20 pmoles) andRNA pool (1.5 nmoles) were incubated in 1 mL of Bind-
ing Buffer (20 mM HEPES pH 7.8, 80 mM KCl, 20 mM
NaCl, 10% glycerol, 2 mM DTT, 0.1 μg/μL BSA) con-
taining 20 μL glutathione sepharose 4B (GE Healthcare)
beads (pre-washed 3 times in Binding Buffer) for 30 min
at 4°C, and subsequently washed four times for 2 min
with Binding Buffer at 4°C. 7-mer Z-scores and motifs
were calculated as described previously [39].
Data access
The BRAT and PUM RIP-Chip microarray data reported
in this study have been deposited in NCBI’s Gene
Expression Omnibus and are accessible through GEO
series accession number GSE60466. The BRAT RNA-
compete data are accessible at GEO Accession Number
GSE60498 and Agilent AMADID number 024519. The
brat mutant time-course microarray data are accessible
through GEO series accession number GSE65661.
Gene annotation enrichment analysis
The DAVID functional annotation tool web server
[42,43] was used to perform enrichment analysis for GO
terms included in the GO FAT database, as well as for
terms included in a number of additional databases: COG
ontology, Swissprot keywords, Uniprot sequence features,
KEGG pathways, PIR Superfamilies, Interpro domains,
and SMART domains, as per the default settings of the
DAVID functional annotation tool. Genes identified as en-
coding BRAT- or PUM-associated mRNAs were analyzed
for enrichment against the background of expressed genes
defined for our RIP-Chip experiments, described above.
Genes identified as upregulated in brat mutant embryos,
in Classes A, B, or C, were analyzed for enrichment
against the background of expressed genes defined in the
brat-mutant time-course microarray experiment (see
below). Terms or features enriched at an FDR of less than
10% and/or a Benjamini P value of less than 0.1 were con-
sidered significant.
Localization pattern enrichment analysis
The subcellular localization, as annotated in the Fly-FISH
database [56], of BRAT- and PUM-associated transcripts,
as well as transcripts upregulated in brat mutant embryos,
was analyzed to ask whether these transcripts were
enriched for particular localization patterns (Fly-FISH an-
notations analyzed were up to date as of March 2014 for
RIP-Chip data, and January 2015 for brat mutant micro-
array data). Analyses of localization patterns for embry-
onic stages 1 to 3 and embryonic stages 4 to 5 were
carried out as described [33], with the following modifica-
tions: all localization terms present in the database were
tested for enrichment, with the exception of the broadest
terms at the top of the database hierarchy with no specific
localization information, which were excluded from
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genes in the background set. Enrichment was determined
using a two-sided Fisher’s exact test, (‘fisher.test’ function
in R software with the alternative hypothesis = ‘two.sided’),
and P values were adjusted for multiple comparisons
using the Benjamini-Hochberg method to determine
FDRs (using the ‘p.adjust’ function in R software with
method = ‘fdr’). FDRs were calculated separately for each
analysis of a single gene list versus a single Fly-FISH devel-
opmental stage. Localization terms enriched at an FDR of
less than or equal to 10% were considered significant.
Genes identified as encoding BRAT- or PUM-associated
mRNAs were analyzed for enrichment against the back-
ground of expressed genes defined for our RIP-Chip experi-
ments, described above. Genes identified as upregulated in
brat mutant embryos, in Classes A, B, or C, were analyzed
for enrichment against the background of expressed genes
defined in the brat mutant time-course microarray experi-
ment (see below).
Comparisons of BRAT- and PUM-associated mRNAs to
translation and stability datasets
For comparisons of BRAT- and PUM-associated mRNAs
to previously published translation and stability datasets,
datasets were obtained either from the publications
themselves [57,59], or were provided to us by the au-
thors [58]. For lists from Thomsen et al. [59], the entire
set of maternally expressed unstable mRNAs in early
embryos was considered as Classes II through V as de-
fined in that publication; mRNAs degraded by the ma-
ternal, or early, pathway, were considered as Classes II
and III (‘exclusively maternally degraded’ and ‘maternally
degraded and transcribed’); and mRNAs degraded by the
zygotic, or late, pathway, were considered as Class IV
(‘exclusively zygotically degraded’). Prior to compari-
sons with PUM- and BRAT-associated mRNAs, all
gene IDs were updated using the ‘Upload/Convert
IDs’ tool available on FlyBase, to IDs consistent with
FlyBase release 5.56. Enrichments and depletions for
comparisons to data summarized in Additional file
10, from Qin et al. [57], De Renzis et al. [58], Thom-
sen et al. [59], Tadros et al. [60], were determined
using a two-sided Fisher’s exact test, followed by multiple
testing correction using the Benjamini-Hochberg proced-
ure to determine FDRs (using R software). Multiple test
corrections were carried out separately for comparisons of
each list of target mRNAs to these datasets. Enrichments
or depletions with an FDR less than 5% were considered
significant.
For analysis of RNAseq data, total developmental
RNAseq data were downloaded from FlyBase release
5.56, and the ratio of RNA (RPKM) in 2- to 4-h embryos
versus 0- to 2-h embryos was calculated. Significant dif-
ferences to the ratios for the set of all expressed genesdefined by our microarray experiments were calculated
using a two-sided Wilcoxon Rank Sum test.
For analysis of translation index data, translation indi-
ces in wild-type embryos were analyzed, and significant
differences to the set of all expressed genes defined by
our microarray experiments were calculated using a
two-sided Wilcoxon Rank Sum test.
Analysis of degradation terms from the Fly-FISH data-
base was carried out as part of the analysis of enrich-
ment of localization terms from the Fly-FISH database,
described above.Drosophila tissue culture and transient transfection
Drosophila S2 cells were maintained in SF 900 III SMF
(Life Technologies) at 25°C. Luciferase reporters carry
the firefly luciferase open reading frame in pRmHa3 [75]
with either six wild-type or six point-mutated BRAT-
binding sites inserted 59 nucleotides downstream of the
luciferase open reading frame’s stop codon. The DNA
sequence of the wild-type array of BRAT-binding sites is:
TTGTTAT A TTGTTAT A TTGTTAT A TTGTTAT A
TTGTTAT A TTGTTAT (‘TTGTTAT’ encodes the
BRAT site and ‘A’ is a spacer), while in the mutated array
all G residues were changed to C. A plasmid carrying the
Renilla luciferase open reading frame inserted into pRmHa3
served as a transfection control. A mixture of 10 ng of
firefly luciferase plasmid, 10 ng of Renilla luciferase plas-
mid, and 380 ng of pSP72 DNA (Promega) was trans-
fected into 0.8 mL of cells at a density of 106 cells/mL
using 1.2 μL of X-tremeGENE 9 (Roche) according to the
manufacturer’s instructions. Firefly and Renilla luciferase
activities were measured approximately 48 h post transfec-
tion using the Dual-Luciferase Reporter Assay System
(Promega) according to the manufacturer’s instructions.
Note that, while expression of the luciferase open reading
frames in pRmHa3 is under the control of the metal-
inducible metallothionein promoter, we did not induce
promoter expression but instead relied on basal-promoter
activity to drive reporter-gene expression. In experiments
involving RNAi knockdown, 0.8 mL of cells at a density
of 106 cells/mL were treated with 5 μg of double-
stranded RNA generated via in vitro transcription using
PCR products as templates. Double-stranded RNA was
generated via in vitro transcription using T7 RNA poly-
merase. The DNA templates for brat knockdown were
generated using primers as described by Weidmann and
Goldstrohm [25], while control double-stranded RNA
was transcribed from a PCR product corresponding to a
portion of the Ampicillin-resistance gene and generated
with the following primers: GGATCCTAATACGACTC
ACTATAGGGAAAGTTCTGCTATGTGGCGCGG and
GGATCCTAATACGACTCACTATAGGGTCCTGCAAC
TTTATCCGC. Three days after the addition of double-
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transfected and their expression assayed as described above.
For analysis of luciferase reporter RNA levels, as well
as quantitation of RNAi-mediated brat knockdown,
RNAi knockdown and transfections were carried out as
described, and approximately 48 h post-transfection cells
were harvested and resuspended in TRI reagent (Mo-
lecular Research Center, Inc., Cincinnati, OH, USA), and
total RNA was isolated following the manufacturer’s
protocol. For each sample, 2 μg of total RNA were treated
with DNase I (Invitrogen, catalog no. 18068–015) accord-
ing to the manufacturer’s protocol. A total of 1 μg of
DNase I-treated RNA was then used to prepare single-
stranded cDNA by reverse transcription using random
hexamer primers and Superscript II reverse transcriptase
(Invitrogen), following the manufacturer’s instructions.
The single-stranded cDNA was used to perform quantita-
tive real-time PCR with primers specific to either the fire-
fly luciferase ORF, the Renilla luciferase ORF, brat, or
RpL32, using SYBR green PCR master mix (ABI) and a
CFX384 Real-Time System (Bio-Rad). Relative levels of
the various transcripts were determined using a standard
curve. In parallel to the reverse transcription, the second
1 μg of DNase I-treated RNA was used in a control no-
reverse transcriptase (no-RT) reaction, which was also
subjected to qPCR and confirmed the measured signal
was not a result of amplification of plasmid or genomic
DNA.
Microarray analysis of brat and w1118 embryo time-course
samples
To compare the transcriptome of wild-type and brat mu-
tant embryos bratfs1/Df(2L)TE37C-7 females were collected
from a cross of bratfs1/CyO flies to Df(2L)TE37C-7/CyO
flies. These females were mated to the males that resulted
from the same cross which consisted mostly of bratfs1/CyO
or Df(2L)TE37C-7/CyO since trans-heterozygotes were pro-
duced at a very low frequency. The resulting embryos failed
to hatch and showed reduced numbers of abdominal seg-
ments (data not shown) consistent with the brat mutant
phenotype [3]. Embryos from w1118 flies served as the wild-
type control. Embryos were collected at 0 to 1.5, 1.5 to 3.0,
3.0 to 4.5, and 4.5 to 6.0 h post egg-laying, dechorionated
in bleach and washed with 0.1% Triton X-100. Embryos
were then disrupted in TRI reagent (Molecular Research
Centre, Inc., Cincinnati, OH, USA), debris was removed by
centrifugation at 14,000 rpm, 4°C for 15 min, and RNA was
isolated following the manufacturer’s protocol.
For microarray analysis of brat mutant and w1118 embryo
time-course samples, double-stranded cDNA was prepared
following the protocol described in the NimbleGen Array
User’s Guide (Gene Expression Arrays, version 6.0), but
using a primer mixture containing 50 ng/μL random hex-
amer primers and 67 pmol/μL anchored-oligo-dT primers.Double-stranded cDNA was prepared from 2.5 μg of total
RNA for each sample. A total of 500 ng of double-stranded
cDNA was labelled with Cy3- or Cy5-tagged random nona-
mers (TriLink BioTechnologies, Inc.) following the Roche
NimbleGen protocol. Labelled cDNA was then hybridized
to custom-designed Drosophila 12 × 135 K NimbleGen ar-
rays (GEO platform number: GPL8593): each array was hy-
bridized with 1 μg each of one Cy3- and one Cy5-labelled
sample, and washed, according to the NimbleGen proto-
col. Three biological replicates were performed for each
time point and each genotype. Arrays were scanned with
a GenePix4000B microarray scanner system (Molecu-
lar Devices, Inc., Sunnyvale, CA, USA). Scanned images
were initially quantified using Nimblescan (Roche) and the
resulting data were normalized using the ArrayStar 12
(DNASTAR) software using the RMA quantile method.
All samples were normalized together.
To identify mRNAs up- or downregulated in brat mu-
tant versus w1118 embryos, microarray data was analyzed
using the Significance Analysis of Microarrays (SAM) [73]
function available in the MultiExperiment Viewer software
application [61,62]. Prior to performing SAM analysis to
identify up- and downregulated transcripts, we first de-
fined the set of mRNAs expressed in our embryo samples
as follows: for each time point and genotype, we defined
the set of expressed transcripts by performing one-class
SAM analysis to identify transcripts whose normalized
signal intensity was significantly greater than the mean
normalized signal intensity of all transcripts represented
on the array (FDR <5%). We then took the union of the
expressed transcripts for all time points in both genotypes,
and defined this as our set of expressed transcripts for the
experiment. After filtering the transcripts present on the
array to only include this set of expressed transcripts, the
normalized microarray signal intensities in the brat mu-
tant versus w1118 embryos at each time point were com-
pared, using SAM two-class unpaired analysis. Genes
significantly higher or lower in the brat mutant compared
to w1118, with an FDR <5%, were defined as up- or down-
regulated in brat mutants. The co-expressed unchanged
transcripts used in the motif enrichment analysis were
those that were defined as expressed but which were less
than 1.1-fold higher or lower in brat mutants, and with an
FDR >50%.
For the purposes of all subsequent analyses, gene IDs were
updated to the most recent version by taking the FlyBase
FBgn IDs present in the array gene description file and up-
dating them using the ‘Upload/Convert IDs’ tool available
on FlyBase, to IDs consistent with FlyBase release 6.03.
K-means clustering of transcripts upregulated in bratmutants
K-means clustering was performed to partition the
union of the transcripts defined as upregulated at any
Laver et al. Genome Biology  (2015) 16:94 Page 27 of 30time point in brat mutant embryos, based only on tran-
script expression in the four time points in w1118 em-
bryos. This analysis was carried out using algorithms
available in the MultiExperiment Viewer software appli-
cation [61,62]: six clusters were chosen to optimally de-
scribe the data based on visual inspection of the Figure
of Merit for k-means clustering, and the k-means clus-
tering algorithm was used to perform the clustering,
using Pearson correlation as the distance metric. Upon
100 repeated iterations of the k-means clustering algo-
rithm with the number of clusters set to six, carried out
using the k-means clustering support tool in the Multi-
Experiment Viewer software, the same six clusters were
generated at least 50% of the time; these were designated
as Classes A through F.
Comparisons of transcripts upregulated in brat mutants
to other datasets
For comparisons of transcripts upregulated in brat mu-
tants to previously published datasets, datasets were ob-
tained either from the publications themselves
[52,53,59], or were provided to us by the authors [58,65].
Lists from Thomsen et al. [59] were: the entire set of
maternally expressed mRNAs in early embryos; the en-
tire set of maternally expressed unstable mRNAs in early
embryos (Classes II through V as defined therein);
mRNAs degraded exclusively by the maternal, or early,
pathway (Class II ‘exclusively maternally degraded’);
mRNAs degraded exclusively by the zygotic, or late,
pathway (Class IV ‘exclusively zygotically degraded’);
mRNAs degraded by both the maternal, or early, and
zygotic, or late, pathways, (Class V ‘both maternally and
zygotically degraded’); and the entire set of zygotically
synthesized transcripts in early embryos (the union of
‘purely zygotic’ and ‘stable + transcription’). Prior to car-
rying out the comparisons, all gene IDs were updated
using the ‘Upload/Convert IDs’ tool available on FlyBase,
to IDs consistent with FlyBase release 6.03. Enrichments
and depletions were determined using a two-sided Fish-
er’s exact test, followed by multiple testing correction
using the Benjamini-Hochberg procedure to determine
FDRs (using R software). Multiple test corrections were
carried out separately for comparisons of each class of
upregulated mRNAs to the published datasets. Enrich-
ments or depletions with an FDR less than 5% were con-
sidered significant. For comparisons to our BRAT RIP-
Chip datasets, tests were carried out with the back-
ground set as the intersection of the list of expressed
genes defined by our RIP-Chip experiment and the list
of expressed genes defined by the time-course micro-
array experiment. For comparisons to datasets describ-
ing maternally- versus zygotically-expressed transcripts,
tests were carried out with the background setconsidered as the list of expressed genes defined for our
microarray experiment, as described above, or the inter-
section of this list of expressed genes and the relevant
background set from the publication, where applicable.
For comparisons to datasets describing maternally
expressed and degraded transcripts, tests were carried
out with the background set as the intersection of the
list of expressed genes defined by our time-course
microarray experiment and the list of all maternally-
expressed genes defined by the relevant publication. For
comparisons to transcripts dependent on Smaug for
their decay, the tests were carried out with the back-
ground set as the intersection of the list of expressed
genes defined by our time-course microarray experiment
and the list of all maternally-expressed and degraded
transcripts defined by Tadros et al. [60]. For compari-
sons to transcripts dependent on the miR-309 cluster of
miRNAs for their decay, tests were carried out with the
background set as the intersection of the list of
expressed genes defined by our time-course microarray
experiment and the union of the lists of all maternally-
expressed and degraded transcripts from Tadros et al.
[60], De Renzis et al. [58], and Thomsen et al. [59]. For
comparisons to Zelda transcriptional targets, the tests
were carried out with the background set as the inter-
section of the list of expressed genes defined by our
time-course microarray experiment and the union of
the lists of all zygotically-expressed transcripts defined
by De Renzis et al. [58] and Thomsen et al. [59].
Assessment of hb RNA stability in brat mutant embryos
To assess the stability of the maternally-expressed hb
transcript (hb-RB) in wild-type and brat mutant em-
bryos, total RNA was isolated from embryos collected
from w1118 or bratfs1/Df(2L)TE37C-7 females, as de-
scribed above for the brat mutant microarray experi-
ment. A total of 50 ng of total RNA was then used to
prepare single-stranded cDNA by reverse transcription
using random hexamer primers and Superscript II re-
verse transcriptase (Invitrogen). The single-stranded
cDNA was used to perform quantitative real-time PCR
with primers specific to the hb-RB transcript, as well as
RpL32 as a control mRNA that is unaffected in brat
mutants, using SYBR green PCR master mix (ABI) and
a CFX384 Real-Time System (Bio-Rad). Relative levels
of the hb-RB and RpL32 transcripts at each time point
for each genotype were determined using a standard
curve.
Additional files
Additional file 1: A figure showing western blots demonstrating
that the anti-PUM and anti-BRAT synthetic antibodies successfully
IP PUM and BRAT.
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(<5%) and fold-enrichment (>1.5-fold enriched) cutoffs, with
associated FDRs and enrichments indicated.
Additional file 3: A table listing all PUM targets passing our FDR
(<5%) and fold-enrichment (>1.5-fold enriched) cutoffs, with
associated FDRs and enrichments indicated.
Additional file 4: A figure showing Venn diagrams comparing PUM-
associated mRNAs and BRAT-associated mRNAs with a previously
published list of mRNAs associated with transgenically expressed
PUM-RBD in whole ovaries [37].
Additional file 5: A table summarizing the results of the cross-
validation analysis for motif discovery based on PUM-associated
mRNAs and BRAT-associated mRNAs, including motifs and AUROCs.
Additional file 6: A file summarizing the results of the BRAT
RNAcompete experiment, including a list of the nucleotide
probabilities associated with the motif calculated from the top 10
7-mers (Figure 2D), as well as a list of the top 100 7-mers.
Additional file 7: A figure showing verification of the BRAT
knockdown for S2 tissue culture cell experiments, by RT-qPCR.
Additional file 8: A file containing tables summarizing the results
of the gene annotation enrichment analyses, performed using the
DAVID functional annotation tool, for all sets and subsets of BRAT
and PUM targets.
Additional file 9: A file containing tables summarizing the results
of the Fly-FISH annotation enrichment analyses, for all sets and
subsets of BRAT and PUM targets.
Additional file 10: A file containing tables summarizing the
results of the comparisons of BRAT- and PUM-associated
mRNAs with various translation and stability datasets included
in Table 3.
Additional file 11: A file containing tables listing the genes whose
transcripts are significantly upregulated in brat mutant embryos at
each of the four time-points assayed, with FDRs and fold-change
values indicated.
Additional file 12: A file containing a table summarizing the results
of the comparison of transcripts up- or down-regulated in brat
mutant embryos to BRAT-associated mRNAs, and the results of
motif enrichment testing for BRAT-binding sites in the 3’UTRs of
transcripts up- or downregulated in brat mutant embryos.
Additional file 13: A file containing tables listing the mRNAs in
each of the six classes of upregulated transcripts, A through F,
generated by k-means clustering.
Additional file 14: Figures showing heat-maps depicting the
expression patterns, in wild-type and brat mutant embryos, of the
mRNAs in each of the six classes of transcripts upregulated in brat
mutants, Classes A through F.
Additional file 15: A file containing tables summarizing the results
of the comparisons of the six classes of transcripts upregulated in
brat mutant embryos (Classes A through F) to various previously
published datasets.
Additional file 16: A file containing tables summarizing the results
of the gene annotation enrichment analyses, performed using the
DAVID functional annotation tool, for those transcripts upregulated
in brat mutant embryos in Classes A through C.
Additional file 17: A file containing tables summarizing the
results of the Fly-FISH annotation enrichment analyses, for
those transcripts upregulated in brat mutant embryos in
Classes A through C.
Additional file 18: A figure showing zygotically expressed hb
mRNA (hb-RA) in wild-type and brat-mutant embryos.
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